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ABSTRACT 
 
 The protozoa are a diverse group of eukaryotic microorganisms that employ a variety of 
life strategies. Many protozoa are free-living while others are commensal organisms that thrive 
within the gut of vertebrates. In addition, a relatively small group of parasitic protozoa 
represent serious health threats to humans and animals.  Certain free-living, commensal, and 
parasitic protozoa are bactivorous and rely on bacteria as a food source.  However, some 
intracellular bacterial pathogens survive engulfment and thrive within these protozoa.  This 
dissertation describes the investigation of Salmonella hypervirulence following bacterial 
engulfment and characterizes physiologic interactions between various protozoa and bacteria. 
Initial studies entailed characterization of in vitro and in vivo Salmonella hypervirulence 
following engulfment by free-living and commensal bactivorous protozoa.  This work revealed 
that Salmonella enterica serotype Typhimurium phagetype DT104 survive protozoan 
engulfment and use the intracellular environment as a venue for plasmid transfer and 
activation of virulence genes. In subsequent studies, receptors from ciliated protozoa were 
investigated with a strategy involving molecular cloning, RNA interference, and heterologous 
expression in yeast.  These studies revealed the involvement of protozoan G protein-coupled 
receptors and a cyclic nucleotide binding protein in bacterial engulfment.  The yeast expression 
system was then used to deorphanize a G protein-coupled receptor from Entamoeba 
histolytica, demonstrating that bacterial lipopolysaccharide is an agonist of this receptor. 
Engulfment assays demonstrated that E. histolytica trophozoites preferred to engulf bacteria 
with intact LPS and this process was sensitive to inhibition of G protein signaling.  In summary, a 
variety of protozoa facilitate salmonellosis, G protein-coupled receptors play a role in bacterial 
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engulfment by protozoa, and these receptors represent novel drug targets worthy of further 
exploration. 
 
 
 
 
 
 
 
 
1 
 
CHAPTER 1: OVERVIEW 
 
 
DISSERTATION ORGANIZATION 
This dissertation describes work investigating the relevance of G protein-coupled 
receptor signaling in bacterial engulfment by protozoa. The first chapter describes the relevant 
organisms, pharmacology, and rationale for the research topic. Chapter 2 characterizes 
Salmonella hypervirulence following engulfment by various bactivorous protozoa in vitro and in 
animal models. Chapter 3 describes mitigation of bacterial engulfment and Salmonella 
hypervirulence with a protozoa-targeted RNAi approach.  Chapter 4 details the identification 
and deorphanization of an intercellular signal-recognizing G protein-coupled receptor from the 
free-living ciliate Tetrahymena.  Chapter 5 provides evidence that the human parasite 
Entamoeba histolytica engulfs bacteria based on deorphanization experiments revealing 
bacterial lipopolysaccharide activation of a G protein-coupled receptor. Chapter 6 summarizes 
the significance of the presented work and suggests avenues for future research. The 
appendices include related and unrelated work accomplished during the time of study.   
 
PROTOZOAN BACTIVORY  
 In addition to predatory bacteria and bacteriophages, bacteria must survive predation 
by bactivorous protozoa.  Bacteria encounter protozoa in the soil, in aquatic environments, and 
in the gastrointestinal tract of vertebrates.  In these habitats, protozoa are significant regulators 
of bacterial populations due to their motility, chemosensory abilities, and voracious appetite for 
smaller microorganisms.  For example, protozoa in the forestomach of ruminants can reduce 
rumen bacterial counts from 4.6x10
10
 to 2x10
9 
[1].  Similarly, under controlled conditions, 
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protozoa are capable of clearing up to 90% of bacteria from a soil sample [2]. Because protozoa 
are such highly effective predators, their eating habits are prominent selective pressures in 
bacterial evolution. 
 
 
 
Figure 1.1. Fluorescently-labeled bacteria within ciliate protozoa  
 
 
Bacterial mechanisms for aversion of predation act at various points in the predator-
prey engulfment process.  Many of these adaptations are designed to evade predation by 
thwarting pre-engulfment events such as chemosensation, contact, and phagocytosis.  To avoid 
detection by protozoa, bacteria secrete soluble substances that inhibit chemosensation.  Rapid 
bacterial motility can be utilized to escape: bacteria capable of traveling faster than 25µm/s are 
able to survive in the presence of bactivorous protozoa [3].  Large or filamentous bacteria are 
bulky and difficult for protozoa to ingest [4].  Similarly, forming biofilms or microcolonies allows 
bacteria reach a size that precludes them from protozoan engulfment.  Biofilms are known to 
produce anti-protozoal toxins such as violacein and other cytotoxins which aid in bacterial 
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escape and survival [5].  In addition to these pre-engulfment mechanisms, some bacteria utilize 
post-engulfment mechanisms to adapt to predation.  For example, bacteria may resist digestion 
in the phagolysosome; some species employing this technique have developed a commensal 
life style as they live within Paramecium [6].                   
  
ENHANCEMENT OF BACTERIAL PATHOGENESIS BY PROTOZOA 
 
 Given the potential lethal consequences of being ingested by a protozoan, it is not 
surprising that bacteria have developed numerous mechanisms for evasion of protozoan 
engulfment.  Interestingly, the very mechanisms developed to avoid predation can be so 
exuberant that the bacteria become capable of virulence in humans or animals.  For example, it 
is hypothesized that protozoan selection pressure has driven the evolution of the Escherichia 
coli Shiga toxin [7].  The type III secretion systems of E. coli, Pseudomonas aeroginosa, and 
Chlamydia are most well known for their roles in bacterial pathogenesis, however, these 
systems are also documented anti-predation mechanisms [8,9].  Biofilms, cell consortia that 
avoid protozoan bactivory, are also a major cause of morbidity and mortality as they form on 
biomedical implants and are more resistant to antimicrobials.  Thus, traits that contribute to 
averting protozoan predation are also bacterial virulence factors. 
 Protozoa are capable of facilitating bacterial pathogenesis and virulence beyond their 
evolutionary influence on the development of bacterial defense mechanisms.  Specifically, 
protozoa can act as a “Trojan horse” that engulf and protect pathogenic bacteria until an 
opportunity to infect a vertebrate arises.  For example, Mycobacterium tuberculosis is capable 
of surviving within free-living protozoa [10].  A more often cited example is Legionella 
pneumophilla which does not reliably replicate extracellularly but is amplified within water-
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born amoebae, thus forming the association between water-based cooling systems and 
Legionnaire’s disease [11].  In the field of water quality, there is interest in “Trojan horse” 
protozoa as they protect bacteria from standard disinfectant procedures and may invalidate 
assays for bacterial pathogens [12].  Interestingly, some species of protozoa, such a 
Paramecium, have endosymbiont bacteria which require the intraprotozoal environment for 
survival [13].   
 
 
      
Figure 1.2.  Summary of bacterial mechanisms for evading protozoa-mediated death and the 
application of these mechanisms by bacterial pathogens. 
 
 
While “Trojan horse” phenomena have been studied mostly in free-living protozoa, it is 
also possible for protozoan parasites to harbor disease-causing pathogens.  For example, 
Trichomonas vaginalis, a venereally transmitted parasite, is capable of carrying Mycoplasma 
hominis [14].  Since both free-living and pathogenic protozoa are capable of harboring 
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intracellular bacterial pathogens, a portion of the work presented investigates commensal 
protozoa which are found in the fore stomachs of ruminants.   
 
SALMONELLA HYPERVIRULENCE INSTIGATED BY RUMEN PROTOZOA 
Salmonella enterica is a Gram-negative, intracellular bacterial pathogen that causes 
food-borne illness throughout the world.  While some serotypes of S. enterica are host-specific, 
S. enterica serotype Typhimurium exhibits a broad host range and is capable of causing disease 
in a variety of vertebrates.  Within this serotype there are numerous subgroups designated by 
the adherence affinity of bacteriophage to a given strain, i.e., the phagetype.  S. enterica 
serotype Typhimurium phage type DT104 (DT104) is a pathogenic isolate which is especially 
virulent and causes severe gastroenteritis in both in both cattle and in humans. The virulence of 
DT104 is due to, at least in part, a chromosomal integron structure known as Salmonella 
genomic island 1 which bears multiple antibiotic resistance genes [15].  
Systemic infection with DT104 requires invasion of the intestinal epithelium, however, 
DT104 is not inherently hyper-invasive [16].  Rasmussen et al. hypothesized that DT104 become 
hyper-invasive and subsequently more virulent following environmental signals from 
commensal protozoa present in the rumen (forestomach) of cattle.  Testing this hypothesis 
revealed that DT104 was almost ten times more invasive in cell culture invasion assays 
following engulfment by rumen protozoa and this effect was recapitulated in a calf infection 
model [17].  These findings were consistently observed with DT104 and other isolates of 
Salmonella containing the Salmonella genomic island 1 integron.  Carlson et al. investigated the 
genetic mechanisms underlying the rumen protozoa-instigated hypervirulence and found that 
SO13, a gene present on genomic island 1, was significantly up-regulated in DT104 following 
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engulfment by bovine rumen protozoa [18].  However, hyperinvasion could not be induced in 
Salmonella lacking the integron but expressing SO13, implying that other genes are needed to 
produce the hyperinvasive phenotype. 
Interestingly, virulence gene hyperexpression is not the only DT104 property augmented 
by rumen protozoa in cattle.  The protozoa engulf and protect DT104 until they are digested in 
the abomasum and the bacteria are released.  Pharmacologic defaunation of rumen protozoa 
from calves abrogated clinical disease and systemic bacterial burden [18].  In addition to 
protection in the harsh environment of the rumen, bovine rumen protozoa act as a venue for 
plasmid transfer.  This phenomenon has been demonstrated in vitro as well as in animal models 
whereby recipient DT104 acquire antimicrobial resistance plasmids from donor bacteria in 
normal calves but not in defaunated animals [19].    
 
Table 1.1.  Summary of mechanisms by which bovine rumen protozoa facilitate Salmonella 
DT104.  
PROPERTY     RELEVANCE TO DT104 PATHOGENESISaaaaaaaaaaa 
Intracellular survival    DT104 passes safely through the rumen 
Induction of SO13 Hyperexpression  Induction of hyperinvasive phenotype 
Venue for plasmid transfer   Acquisition of antibiotic resistance plasmids 
 
 
 Rumen protozoa are fastidious and few investigators have been able to successfully 
propagate these microbes for extended periods of time.  Therefore, relatively few studies of 
rumen protozoa taxonomy and genetics have been undertaken and there are no established 
genetic databases available for these microbes.  This severely hampers the utility of 
bioinformatic and molecular biology approaches for the study of rumen protozoa.  Recent 
metagenomic studies indicate that the major genera of rumen protozoa are ciliates, namely, 
Entodinium, Epidinium, Dasytricha, and Isotricha [20,21].  Tetrahymena thermophila is a related 
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free-living bactivorous ciliate that was selected as a model for several of the studies presented 
herein. Tetrahymena is easily cultured and there are numerous bioinformatic resources 
available for this organism.  In addition, Tetrahymena is amenable to RNAi-based gene 
knockdown [22].  Studies in chapters 3 and 4 utilize this organism in the investigation of 
protozoan receptors associated with bacterial engulfment. 
 
ENTAMOEBA HISTOLYTICA: A BACTIVOROUS PROTOZOAN PARASITE 
 While free-living or commensal protozoa contribute to bacterial pathogenesis, some 
protozoa are infectious parasites with the inherent ability to cause severe disease in humans 
and animals.  Protozoan parasites represent diverse taxa and each has a preferred host tissue 
habitat.  Depending on the particular organism, protozoan parasites can be found in blood, 
skeletal muscle, mucosal surfaces, or the gastrointestinal tract.  Entamoeba histolytica, an 
anthroponotic amoeba, inhabits the intestine and is relevant to the work presented herein 
since it actively engulfs bacteria as a major source of nutrition [23]. 
 E. histolytica is a cosmopolitan parasite that causes amebic colitis and systemic 
amebiasis.  Amebiasis results in 100,000 deaths annually which is only second to malaria in 
terms of death by a protozoan [24].  E. histolytica is spread by a fecal-oral route and the life 
cycle consists of two distinct life cycle stages.  Quadrinucleate cysts are shed in the feces and 
are the infective stage.  Cysts survive the low pH of the stomach and excyst in the illeocecal 
region to form trophozoites that are pleomorphic, motile, and capable of reproduction by 
binary fission.  Some trophozoites form the infective cyst stage following an unknown stimulus; 
they do not encyst in vitro.  The amoebic galactose/N-acetylgalactosamine lectin binds to 
colonic epithelial cells; host cells are then killed by a combination of apoptosis induction and 
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insertion of pore-forming peptides [25].  Invasion of the mucosa and submucosal tissues results 
in nearly pathognomonic flask-shaped tissue ulcers (Figure 1.3).  Sequelae to amoebic colitis 
include colonic perforation, ameboma, and rectovaginal fistulae.  More rarely, trophozoites 
gain access to the blood stream and cause liver or brain abscesses [26].    
 
 
 
 
Figure 1.3. Characteristic flask shaped ulcer caused by E. histolytica.  (Photo From: Stanley, 2003 
[27]) 
 
 
 
 E. histolytica has persisted throughout the world, in part due to the fact that there are 
few pharmacologic agents available for the treatment of the disease.  Several vaccines are 
described in the literature, although no commercial vaccine is currently in use [28].  The main 
class of drugs used for amebiasis are the nitroimidazoles, mainly metronidazole, which are 
thought to bind and fragment DNA thus inhibiting DNA replication.  These drugs are mutagenic 
in bacterial systems and carcinogenic in animal models, therefore, they are considered 
undesirable [29].  In addition, metronidazole elicits neurological side effects and is not for use in 
pregnant individuals [29].  Drug resistance is also becoming an increasing concern since E. 
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histolytica possesses nitroimidazole reductases and P glycoprotein-like transporters that 
inactivate or efflux metronidazole, respectively [30,31].  Thus, the limitations of anti-amoebic 
therapy warrant investigation into new molecular targets that are unique in protozoa and could 
be exploited.         
 The hypothesis for this work presented in chapter 5 was that E. histolytica expresses a 
bacterial recognition receptor.  The aim of identifying this receptor and its cognate ligand was 
to further understand the bacterial engulfment and to identify a unique amoebic receptor that 
could provide a new candidate for anti-amoebic therapy. 
 
G PROTEIN-COUPLED RECPTORS 
 
G protein-coupled receptors (GPCRs) are the largest known superfamily of 
transmembrane proteins and are broadly defined by their structure consisting of seven 
transmembrane-spanning α domains.  Upon activation by a ligand, GPCRs convert an 
extracellular stimulus to an intracellular signal by activating cognate G proteins.  G proteins are 
signal transduction proteins with the ability to bind guanosine triphosphate (GTP) and 
guanosine diphosphate (GDP).  Some G proteins are small and consist of a single subunit 
whereas most GPCRs associate with heterotrimeric G proteins consisting of α, β, and γ subunits 
[32].   
In the absence of a signal, the heterotrimeric G protein is associated with a GPCR and 
the α subunit is bound to GDP.  Following ligand binding, GPCRs activate the G protein by 
inducing a conformational change resulting in the replacement of GDP with a GTP.  The GTP-
bound α subunit then disassociates and activates downstream signaling pathways that vary 
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depending on the Gα subtype.  These signal transduction pathways lead to accumulation or 
depletion of second messenger molecules that instigates a biological effect [32,33].   
 The main families of G protein α subunits are Gαs, Gαi, Gαq, Gα12/13.  Gαs and Gαi are 
named to indicate that they stimulate or inhibit adenylate cyclase, respectively, which catalyzes 
the conversion of adenosine triphosphate (ATP) to cyclic adenosine monophosphate (cAMP) 
[32,34].  Gαq activates phospholipase C, leading to the cleavage of phosphatidylinositol 4,5-
bisphosphate (PIP2) that results in the production of diacyl glycerol and inositol 1,4,5-
triphosphate (IP3).  IP3 activates ion channels on endoplasmic reticulum which release Ca
2+
 into 
the cytosol [32,34].  Gα12/13 is the least well characterized; it is thought that this family activates 
Rho GTPase nucleotide exchange factors (RhoGEFS) [35].  RhoGEFS catalyze the exchange of 
GDP for GTP by GTPase RhoA which ultimately leads to activation of Rho kinases (ROCK) and 
subsequent downstream biologic activity, including gene transcription and cytoskeletal 
movement [35].  Thus, seven transmembrane GPCRs are mostly associated with heterotrimeric 
G proteins but there is a growing number of receptors that interact with other cell signaling 
molecules.    
GPCRs are expressed by all cells in vertebrates where they modulate a remarkable 
diversity of physiologic functions.  GPCR ligands include catecholamines, peptides, purines, and 
even photons.  Therefore, GPCRs mediate a variety of senses and homeostatic functions.  It is 
not surprising then, given their importance, that 36% of the currently marketed drugs target 
GPCRs [36].  The central goal of the work presented herein was to characterize GPCRs from 
protozoa since these targets could be used to kill protozoan parasites or abrogate protozoan 
enhancement of bacterial pathogenesis.    
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Figure 1.4.   Overview of signal transduction pathways activated by GPCR signaling via Gαs, Gαi, 
and Gαq. 
 
 
HISTORY OF GPCR STUDIES IN PROTOZOA 
 GPCRs are expressed in animals, fungi, and bacteria.  Protozoa represent vastly diverse 
taxa and the study of GPCRs in these organisms is only in its infancy.  The first impediment to 
the study of protozoan GPCRs is that genomic resources and tools for studying these organisms 
have become available relatively recently compared to those for vertebrates.  In addition, the 
biology of protozoa complicates their study when they are considered in light of scientific 
paradigms that are essentially formed solely based on the study of vertebrates.  Protozoa utilize 
alternate codon usage (such as read-through stop codons), possess distinct unique organelles, 
and utilize a variety of chromosomal organizational schemes [37,38].  Therefore, progress in 
protozoan GPCR research has advanced slowly.   
 Several tiers of evidence supporting the existence and function of protozoan GPCRs 
exist.  The most abundant, yet least convincing, evidence for GPCR signaling in protozoa is that 
protozoa exhibit physiological or behavioral responses to classical GPCR ligands.  For example, 
Tetrahymena synthesizes biogenic amines and exhibits chemotactic responses when presented 
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with ligands for vertebrate GPCRs [39,40].  Entamoeba invadens, a parasite of reptiles, 
produces cAMP when stimulated with epinephrine and this phenomenon is sensitive to 
modulators of heterotrimeric G proteins such as pertussis toxin and cholera toxin [41].  
Additional supportive indirect evidence is the identification of GPCR signal transduction 
machinery in protozoa.  For example, heterotrimeric G proteins have been identified in 
Dictyostelium, Trichomonas vaginalis, Entamoeba, and other protozoa [42-44].  Database 
searches reveal GPCRs in the genomes of several protozoa and knock out mutants have 
suggested the function of some of these receptors. For example, knocking out GPCR6 from 
Tetrahymena resulted in decreased G protein activity and decreased chemotaxis, leading 
investigators to hypothesize that this receptor is a constitutively active GPCR [45].  Knocking-
out GPCRs from the amoeba Dictyostelium, termed crl receptors, suggests that these receptors 
detect cAMP in the environment [46].  Picazarri et al. identified EhGPCR-1, a GPCR from E. 
histolytica with a putative role in phagocytosis [47].  This receptor was chosen as a subject for 
the presented studies with the hypothesis that EhGPCR-1 could bind bacterial ligands and 
induce bacterial engulfment. 
 A range of physiologic evidence supports GPCR existence and function in protozoa and 
numerous putative GPCR-encoding sequences can be found in genetic databases for protozoa.  
However, no studies have attempted to heterologously express these protozoan GPCRs in an 
attempt to reveal their cognate ligand.  Therefore, a goal of this study was to utilize the yeast 
system described in the section below as it could offer a method for studying protozoan GPCRs.    
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GPCR DEORPHANIZATION AND A HETEROLOGOUS YEAST EXPRESSION SYSTEM 
 
 Initially, studies of GPCRs relied on the identification of a biological molecule that 
exerted a physiological response in cell cultures or tissue preparations.  Following identification 
of a ligand, investigators would attempt to establish a cognate receptor.  However, the advent 
of the polymerase chain reaction and molecular cloning significantly altered this method and 
established the more popular and successful modern practice of reverse pharmacology.  Under 
this approach, a GPCR is identified on the basis of its DNA sequence.  Therefore, the ligand is 
not initially known and the receptor is known as an orphan GPCR.  Upon discovery of the ligand 
the receptor is considered deorphanized. 
 Reverse pharmacology typically begins with homology screening approaches and 
degenerate PCR used to clone GPCR-encoding sequences.  The cloned receptors are then 
expressed in a heterologous cell system and interrogated with potential ligands.  Receptors 
have been expressed in Xenopus oocytes and a variety of mammalian cell lines [33].  In these 
systems, GPCR activation is often assayed by fluorometric detection of calcium flux or 
measurement of other second messengers such as cAMP or inositol phosphates.   
 An interesting heterologous expression system has been designed that utilizes the 
common yeast, Saccharomyces cerevisiae.  Knockout S. cerevisiae strains lack endogenous 
GPCRs and can be used for a convenient deorphanization platform [48].  In yeast, GPCRs bind 
pheromones from neighboring cells and activate the promoter Fus1.  In these particular yeast 
strains, Fus1 controls the expression of His3 that confers the ability to synthesize histidine de 
novo.  Therefore, activation of a heterologously expressed GPCR results in Fus1 activation, 
subsequent His3 expression, and the ability to grown in histidine-deficient media [48-50].  
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Therefore, receptor activation can be measured by a simple growth assay.  The yeast has been 
further modified by replacing the unique yeast G protein Gpal with amino acid residues from the 
C-terminus mammalian Gα.  The resulting G protein is referred to as a “Gα transplant” which is 
promiscuous and exhibits high binding efficiency with non-yeast GPCRs [51].   
Yeast heterologous expression was used to deorphanize the human β2 adrenergic 
receptor as well as other mammalian GPCRs.  More recently, the yeast expression system has 
been used to study the pharmacology of GPCRs from nematodes and arthropods [49,50].  A 
goal of the studies presented in this work was to utilize the yeast expression system as a tool to 
deorphanize putative GPCRs from protozoa.     
 
PURPOSE 
 Rumen protozoa-mediated facilitation of salmonellosis warrants further investigation 
given the importance of DT104 in human and animal disease.  It is not known if commensal 
protozoa from other ruminants are capable of facilitating DT104 in terms of activating the 
hyperinvasive phenotype or acting as a site of conjugal plasmid transfer.  Because protozoa are 
so abundant in the environment and in the rumen of food animal species, the first specific aim 
of this work was to determine if commensal protozoa from other ruminants are capable of 
facilitating DT104.    
The aim of the second phase of studies presented herein was to identify and 
deorphanize protozoan GPCRs.  Characterization of protozoan GPCRs associated with protozoan 
bactivory are of broad interest in microbiology and evidence for GPCRs in protozoa is desirable 
in terms of general biological knowledge.  In addition, GPCR characterization from protozoa 
may provide a means by which to ameliorate disease.  First, targeting of GPCRs could be utilized 
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in the abrogation of rumen protozoa facilitated salmonellosis.  Second, GPCRs from protozoan 
parasitic pathogens such as E. histolytica represent novel chemotherapeutic targets of interest 
in the development of new anti-protozoal agents.  Revealing the ligands of putative protozoan 
GPCRs will help clarify their physiologic significance and reinforce interest in these receptors as 
drug targets.      
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CHAPTER 2.  COMPARISONS OF SALMONELLA CONJUGATION AND VIRULENCE GENE 
HYPEREXPRESSION MEDIATED BY RUMEN PROTOZOA FROM DOMESTIC AND EXOTIC 
RUMINANTS 
 
Modification of a paper published in Veterinary Microbiology 
 
Matt T. Brewer, Nalee Xiong, Jeffery D. Dier, Kristi L. Anderson, Mark A. Rasmussen, Sharon K. 
Franklin, and Steve A. Carlson  
 
ABSTRACT 
 
Recent studies have identified a phenomenon in which protozoa engulf Salmonella and 
the intra-protozoal environment hyperactivates virulence gene expression and provides a 
venue for conjugal transfer of antibiotic resistance plasmids.  The former observation is 
relegated to Salmonella bearing the SGI1 multiresistance integron while the latter phenomenon 
appears to be a more generalized event for recipient Salmonella.  Our previous studies assessed 
virulence gene hyperexpression only with protozoa from the bovine rumen while conjugal 
transfer has been demonstrated in rumen protozoa from cattle and goats.  The present study 
examined virulence gene hyperexpression for Salmonella exposed to rumen protozoa obtained 
from cattle, sheep, goats, or two African ruminants (giraffe and bongo).  Conjugal transfer was 
also assessed in these protozoa using Salmonella as the recipient.  Virulence gene 
hyperexpression was only observed following exposure to the rumen protozoa from cattle and 
sheep while elevated virulence was also observed in these animals.  Conjugal transfer events 
were, however, observed in all protozoa evaluated.  It therefore appears that the protozoa-
based hypervirulence is not universal to all ruminants while conjugal transfer is more 
ubiquitous.     
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INTRODUCTION 
Salmonella enterica is a major cause of food borne illness throughout the world.  
Treatment of salmonellosis is becoming increasingly difficult as many stains are resistant to 
multiple antibiotics.  This is especially true for S. enterica serotype Typhimurium phage type 
DT104 (DT104), which is resistant to five or more antibiotics as a result of the acquisition of an 
integron structure designated as Salmonella genomic island 1 [SGI1, [1]]. 
Recent studies revealed that rumen protozoa (RPz), commensal microbes inhabiting the 
forestomach of ruminants, provide a venue for conjugal transfer where Salmonella can acquire 
plasmid-borne antibiotic resistance genes [2].  Whereas many other bacteria are digested by 
RPz, Salmonella is an intracellular pathogen which is able to live, multiply, and accept 
conjugative plasmids within these microbes [2,3].   
 In addition to mediating antibiotic resistance gene transfer, RPz hyperactivate 
Salmonella virulence in strains bearing the SGI1 integron.  In this model, RPz engulf Salmonella 
and induce overexpression of hilA, a transcriptional regulator of invasion [4].  HilA 
overexpression is in response to expression of SO13, an SGI1 gene with unknown function [5].  
The resulting hyperinvasion leads to a faster onset of clinical signs, a greater recovery rate of 
the pathogen, and a poorer prognosis.  This is especially evident in cattle where DT104 is 13 
times more likely to die than calves infected with antibiotic-sensitive S. enterica serovar 
Typhimurium [6]. 
 To assess this phenomenon in other ruminants, we assessed RPz isolated from goats, 
sheep, and two exotic ruminants (bongo and giraffe).  RPz from these animals were evaluated 
21 
 
for the ability to induce virulence gene hyperexpression and foster plasmid conjugation in 
Salmonella.      
 
MATERIALS AND METHODS 
Summary of microbes used in this study  
Bacterial strains are summarized in Table 2.1 with strain 98-420 serving as the model 
DT104 isolate and strain TH11 serving as the DT104 isostrain lacking SGI1 [7].  Bacteria were 
stored in cryopreservation tubes containing 50% glycerol:50% culture medium at -80°C and 
were grown in LB broth (Sigma) without antibiotics for TH11, with ampicillin plus 
chloramphenicol (32µg/mL each; Sigma) for DT104, or with ceftiofur (32µg/mL; Pfizer) for 
Klebsiella.  
Rumen fluid was removed from fistulated animals as described previously [3].  Fluid was 
filtered to remove large particulate matter and mixed with an equal volume of Coleman’s 
buffer D [8].  Protozoa were then allowed to settle for 2 h under CO2.  Settled protozoa were 
aspirated and washed twice with approximately 45ml Coleman’s buffer D and then centrifuged 
for 20 s at 230 x g.  Pelleted protozoa were resuspended in 30 mL Coleman’s buffer D under 
CO2.   One milliliter was used for enumeration, and 3 mL (approximately 10
5
 RPz) was used in 
each invasion assay.   
RPz were isolated from individually housed giraffe (Giraffa camelopardalis) and bongo 
(Tragelaphus eurycerus) at the Blank Park Zoo in Des Moines, IA, USA.  Regurgitated rumen 
contents were collected from the surface of watering tanks and suspended in 300 mL 
Coleman’s buffer.  This solution was immediately filtered through cheese cloth to remove 
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particulate matter and then centrifuged at 300 x g for 3 minutes.  The pellet was resuspended 
in 10 mL of Coleman’s buffer and a hemocytometer was used to determine an estimated RPz 
concentration of 10
5
/mL.  Trypan blue staining revealed approximately 90% viability of the RPz, 
which is consistent with previous studies employing this method of RPz.  Control studies 
revealed that this sampling method yielded viable bovine RPz that facilitated plasmid transfer 
and hyperinvasion (data not shown).  
 
Salmonella invasion assays following survival within RPz 
 10
5 
RPz were co-incubated with 2x10
8 
CFUs Salmonella and agitated with a tube roller 
for 24 h at room temperature in a 1.5mL microcentrifuge tube.  Extracellular Salmonella were 
then killed using 300µg/mL florfenicol (Schering-Plough).  RPz were then lysed for 60 sec at 
4,800 rpm using 2.5 mM glass beads and a mini-beadbeater (Biospec Products).  The recovered 
lysate was pelleted and resuspended in 350uL LB broth and 50 µL was plated on XLT agar 
(Difco) to assess engulfment of Salmonella.  The remaining bacteria were incubated with HEp-2 
cell cultures in triplicate.  Specifically, 100 µL was added to each tissue culture well containing 
10
5
 HEp-2 cells which were maintained in RPMI 1640 (GIBCO) containing 10% fetal bovine 
serum at 37°C in a 5% CO2 humidified incubator.  The protozoa-derived bacteria were incubated 
with HEp-2 cells for 1 h at 37°C and extracellular bacteria were then killed using 300µg/mL 
florfenicol.  HEp-2 cells were then lysed for 15 min at 37°C using 0.1% Triton-X.  Dilutions of the 
lysate were plated on Salmonella selective media and grown overnight at 37°C followed by 
enumeration the next day.  Percent invasion was calculated by dividing CFUs recovered by CFUs 
added. 
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Conjugation Frequency Assay 
Approximately 10
9
 CFUs of both S. enterica serotype Typhimurium strain TH11 [7] and K. 
pneumoniae TCR2003 [2] were co-incubated with approximately 10
5
 RPz in sealed glass tubes 
overnight on a rocker at 37°C.  At the end of the incubation period, extracellular Salmonella 
were killed using 300µg/mL florfenicol.  RPz were then lysed using a bead beater for 60 sec.  
The lysate was pelleted and resuspended in 200 mL Lennox L broth.  Next, 50 µL was spread on 
Brilliant Green Agar (does not support the growth of Klebsiella; Difco) containing 32µg/mL 
ceftiofur.  Plates were incubated at 37°C overnight and colonies were enumerated the next day.  
Conjugation frequency was determined by calculating CFUs of ceftiofur-resistant Salmonella 
recovered divided by CFUs of ceftiofur-sensitive Salmonella added to the assay. 
 
In vivo infection experiments 
10
6
 CFUs/kg of DT104 was orally inoculated into 8-week old Holstein calves (n=6, 
approximately 70kg each, male), adult sheep (n=6, approximately 100kg each, female, mixed 
breeds), and goats (n=6, approximately 100kg each, female, mixed breeds) that harbored native 
populations of RPz.  Animals were monitored for changes in appetite, stool consistency, and 
rectal temperature every 8 to 12 h.  At the onset of signs related to systemic salmonellosis, 
animals were euthanized using xylazine (0.5 mg/kg intramuscularly; Phoenix Laboratories) and 
pentobarbital (1.2 mg/kg, intravenously; Fort Dodge Laboratories).  Splenic samples, which are 
a reliable indicator of systemic burden [3,5], were collected following euthanasia.  
Spleens were aseptically cut into small pieces, placed in an equal volume of LB broth, 
and vortexed vigorously for 2 min.  Dilutions of the resulting homogenate were plated on XLT 
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agar containing ampicillin (32µg/mL) and chloramphenicol (32µg/mL) for enumeration.  
Salmonella colonies were confirmed by PCR using primers specific for detection of the sipB-sipC 
gene fragment as described previously [7].  
Semi-Quantitative RT-PCR 
RT-PCR was conducted to assess the expression of hilA and SO13.  RNA was isolated 
from bacteria using the RNeasy Mini Kit with enzymatic lysis for the initial cell disruption 
(Qiagen).  RT-PCR was carried out using the SuperScript One-Step RT-PCR with Platinum Taq kit 
(Invitrogen) using the hilA or SO13 primers and PCR conditions described previously [5].  The 
number of cycles in the PCR portion of the reaction was varied to empirically determine the 
number of cycles required to produce a visible amplicon from the Salmonella RNA template 
collected from each specimen.  RT-PCR products were visualized on a 1.5% percent agarose gel 
using ethidium bromide staining.  
 
RESULTS 
Assessment of Klebsiella to Salmonella conjugal transfer of antibiotic resistance plasmids within 
RPz from various ruminants 
Our previous studies revealed that Salmonella can conjugate and receive antibiotic 
resistance plasmids while co-habitating in RPz obtained from cattle and goats [2].  To determine 
if this phenomenon extends beyond these two domestic ruminants, a plasmid-bearing donor 
strain of Klebsiella was co-incubated with recipient Salmonella in the presence of RPz obtained 
from sheep and two African ruminants.  The giraffe was chosen because a previous study 
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demonstrated that these ruminants have unique RPz [9].  The bongo was chosen since it is a 
member of the Bovidae family and thus their RPz may behave like cattle RPz. 
Conjugation was measured by enumerating recovered ceftiofur-resistant Salmonella 
since the Klebsiella bears a plasmid encoding an extended-spectrum beta-lactamase [2].  As 
shown in Table 2.2, the Klebsiella-to-Salmonella plasmid transfer events were also observed in 
RPz obtained from sheep, giraffe and bongo.  Conjugation frequencies were slightly higher in 
RPz obtained from the African ruminants although this difference may not be biologically 
significant.  
 
Assessment of DT104 hyperinvasion after exposure to RPz obtained from various ruminants 
Our previous studies revealed that SGI1-bearing strains of Salmonella are hyperinvasive 
after exposure to RPz obtained from cattle.  To determine if this phenomenon extends beyond 
cattle, SGI1-bearing Salmonella were evaluated for ovine and caprine RPz-mediated alterations 
in invasiveness using a HEp-2 tissue culture cell invasion assay.  Additionally, we assessed this 
phenomenon in RPz obtained from the bongo and giraffe.  The hyperinvasive state of DT104 
was compared to that of TH11, a strain that lacks SGI1 and therefore is not capable of exhibiting 
the RPz-mediated hyperinvasive phenotype [3,5].  
As shown in Figure 2.1, DT104 invasion was increased following recovery from bovine 
RPz which is consistent with previous data [3,5].  DT104 recovered from ovine RPz were also 
significantly more invasive when compared to that observed for TH11 although the increase in 
invasiveness was not as robust as the increase noted in the presence of bovine RPz.  For all 
other RPz examined, invasiveness was indistinguishable for DT104 and TH11.  
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Assessment of RPz-mediated Salmonella hypervirulence in vivo  
 Previous studies indicated that RPz-mediated hyperinvasion is a predictor of 
hypervirulence in vivo [3,5].  In the present study we assessed clinical outcomes in calves, 
sheep, and goats infected with DT104 exposed to RPz.  Studies involved monitoring the clinical 
signs and culturing splenic samples from infected animals.  Control animals were infected with 
TH11 lacking SGI1 [3,5]. 
As depicted in Figure 2.2, significantly more DT104 were recovered from calves and 
sheep when compared to goats.  Similarly, calves and sheep demonstrated pyrexia at 24-48 hr 
post infection whereas goat rectal temperatures did not differ from normal (Figure 2.3).   
  
 Assessment of SO13 and hilA expression in DT104 inoculated into cattle and sheep 
 Our previous studies indicated that RPz-mediated hypervirulence in DT104 is associated 
with enhanced expression of hilA and SO13 following protozoal engulfment [5].  In the present 
study, a semi-quantitative RT-PCR was used to determine relative expression levels of hilA and 
SO13 in DT104 and TH11 recovered from calves, sheep, and goats.   
As shown in Figure 2.2, RPz-mediated hypervirulence was associated with increased 
expression of hilA and SO13 in DT104 recovered from calves and sheep.  This was especially 
evident for the SO13 amplicon that could be amplified from DT104 recovered from calves and 
sheep in the primary RT-PCR reaction.  In contrast, secondary and tertiary PCR reactions were 
required before a visible amplicon could be generated in TH11 recovered from all animals and 
from DT104 recovered from goats. 
27 
 
DISCUSSION 
 Previously we have demonstrated that DT104 exhibits hypervirulence following 
exposure to RPz obtained from cattle [3,5].  Additionally, bovine and caprine RPz can serve as 
venues for plasmid acquisition by Salmonella [2].  The study herein describes experiments 
addressing the hypothesis that these phenomena extend to an array of RPz obtained from 
domestic and exotic ruminants although the exotic ruminants were housed in a domestic 
environment. 
 Plasmid transfer studies revealed that all RPz tested could serve as facilitators for this 
event.  This finding is consistent with our unpublished observations that free-living protozoa, 
such as Tetrahymena and Acanthamoeba, can mediate plasmid transfer into Salmonella.  
Additionally, our preliminary studies suggest that Salmonella can acquire antibiotic resistance 
genes while residing within pathogenic Eimeria and Trichomonas (not shown).  That is, 
Salmonella appears to be able to conjugate with other bacteria in a wide array of protozoa.  
Based on our previous studies, it is unclear if this conjugation process can occur within 
mammalian cells that engulf or are passively invaded by Salmonella [2].  Differences in 
intracellular trafficking may account for this divergence. 
 The instigation of hypervirulence, however, is not as ubiquitous.  Hyperinvasion and 
hypervirulence were noted only for Salmonella exposed to RPz obtained from cattle and sheep.  
Expression of SO13 and hyperexpression of hilA were associated with the augmented invasion 
and virulence observed in sheep in a manner similar to our previous and current findings with 
cattle.  There does appear to be a difference in the clinical progression of hypervirulence in 
cattle versus sheep, while the disease course in goats was unremarkable.  We hypothesize that 
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differences in RPz profiles account for the non-conserved nature of the 
hyperinvasion/hypervirulence.  Isotricha is a putative non-engulfing RPz [3] that may be 
relatively less abundant in the bovine and ovine rumens.  Alternatively, sheep and cattle 
rumens may contain unique RPz that engulf and modulate gene expression in Salmonella.  The 
time of day, time after feeding, and diet are other factors influencing RPz profiles [11,12].  
 In summary, the phenomenon of RPz-mediated Salmonella gene transfer is viable in 
cattle, sheep, goats, bongo, and giraffe.  The RPz-hypervirulence phenomenon is relegated to 
cattle and sheep.  RPz profiles are the likely determinant of the divergence regarding the latter 
phenomenon. 
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Table 2.1.  Summary of microbes used in this study. 
 
Microbe Relevant Characteristics Reference 
Salmonella 
enterica serotype 
Typhimurium 
DT104 strain 98-
420 
SGI1-bearing strain capable of 
exhibiting hypervirulence 
following exposure to RPz 
[3] 
Salmonella 
enterica serotype 
Typhimurium 
DT104 strain 
TH11 
SGI1-free isostrain of DT104 
incapable of hyperinvasion 
[7] 
Klebsiella 
pneumoniae 
TCR2003 
Isolated from turtle feces in 
Iowa; bears a ceftiofur 
resistance plasmid 
[2] 
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Table 2.2.  Summary of Klebsiella-Salmonella gene transfer events observed in vitro.  K. 
pneumoniae TCR2003 was used as the donor strain in all studies.  Experiments used 10
9
 
potential recipients, 10
9
 donors, and 10
4
 RPz.  
 
Salmonella 
recipient 
RPz source 
 
Replicates 
 
Number of ceftiofur- resistant 
Salmonella recovered/109 
recipients (mean + sem) 
TH11 Bovine  12 408 + 85 
TH11 Caprine  12 387 + 115 
TH11 Ovine  12 298 + 37 
TH11 Bongo  12 877 + 83 
TH11 Giraffe  12 1094 + 27 
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Figure 2.1.  Assessment of HEp-2 cell invasion by SGI1-bearing (DT104) or SGI1-free (TH11) 
Salmonella recovered from RPz.  The source of the RPz is indicated on the y-axis.  Each bar 
represents the mean ± standard error for 12 replicates. 
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Figure 2.2.  Assessment of bacterial loads and semi-quantitative analysis of virulence gene 
expression for Salmonella DT104 or TH11 exposed to RPz in sheep, calves, and goats.  Left side, 
virulence gene expression of hilA and SO13 in DT104 (upper sets of numbers) and TH11 (lower 
sets of numbers) recovered from calves, sheep, and goats.  Values indicate the number of PCR 
cycles necessary to generate a visible SO13 or hilA amplicon following an RT-PCR assay.  Right 
side, quantitation of DT104 (filled bars) or TH11 (open bars) recovered from splenic samples of 
animals infected with the pathogens.  Each bar represents the mean ± sem for 6 animals.* 
Indicates hyperexpression. 
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Figure 2.3.  Onset of pyrexia in calves, sheep, and goats orally infected with DT104.  Rectal 
temperatures were determined every 8 to 12 hours.  The upper limit for normal bovine rectal 
temperature (~102.5
o
F) is indicated by the horizontal line.   Each point represents the mean ± 
sem for 6 animals. 
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CHAPTER 3.  RNAi-MEDIATED INHIBITION OF SALMONELLA HYPERVIRULENCE INSTIGATED BY 
TETRAHYMENA 
 
 
Matt T. Brewer and Steve A. Carlson 
 
ABSTRACT 
 
Recent studies have identified a phenomenon in which rumen protozoa engulf 
Salmonella and the harsh intracellular environment induces virulence gene expression and a 
hyperinvasive phenotype.  In the present study, we investigate the hyperinvasive behavior of 
Salmonella DT104 following engulfment by Tetrahymena thermophila, a free-living ciliate.  We 
evaluate the use of siRNA designed to target the expression Tetrahymena genes with a 
potential role in bacterial engulfment. Protozoa-mediated Salmonella hypervirulence, as 
measured by an in vitro cell invasion assay and an in vivo calf infection study, was observed 
following engulfment by Tetrahymena. Electroporation of Tetrahymena with siRNA targeting 
expression of a putative cyclic nucleotide binding protein designated TetCNB-1 resulted in 
decreased expression of CNB1.  Decreased CNB1 expression was associated with inhibition of 
bacterial engulfment and inability to induce the DT104 hyperinvasive phenotype.  These data 
suggest that TetCNB-1 is associated with the engulfment and intracellular processing of 
bacteria.  In conjunction with an RNAi-based approach, Tetrahymena may offer a useful model 
for the study of rumen protozoa-mediated Salmonella hypervirulence.   
 
INTRODUCTION 
Protozoa are predators that readily consume bacteria as a nutrient source.  However, 
several bacterial taxa are capable of resisting degradation by protozoa and thriving within these 
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cells [1].  This observation is relevant to intracellular bacterial pathogens since intra-protozoal 
survival implicates protozoa as environmental reservoirs for these organisms [2,3].  Such 
symbioses are not restricted to environmental protozoa.  In the case of Salmonella enterica 
serotype Typhimurium phagetype DT104 (DT104), bacteria survive engulfment by commensal 
rumen protozoa located in the foregut of ruminants.  Here, DT104 is protected from the harsh 
environment of the rumen until they are transported to the abomasum where the protozoa are 
degraded and DT104 is released [4,5].   
 In addition to their protective role, rumen protozoa (RPz) enhance the virulence of 
DT104.  First, they provide a site of conjugal plasmid transfer where Salmonella can acquire 
antibiotic resistance genes [6,7].  Second, engulfment of DT104 by RPz stimulates 
hyperexpression of bacterial virulence genes leading to the induction of a hyper-invasive 
phenotype that results in faster onset of clinical signs and a greater recovery rate of the 
pathogen [4,5].  Conjugal plasmid transfer is observed in a variety of commensal and free-living 
protozoa while protozoa-mediated hypervirulence is initiated only in RPz from sheep and cattle 
[4-6].  Protozoa-mediated hypervirulence is restricted to DT104 strains bearing a virulence gene 
cassette designated Salmonella genomic island 1 (SGI1) [4,5].  Other taxa of protozoa also 
hyperactivate SGI1-bearing strains of DT104.  For example, the amoeboid protozoan 
Acanthamoeba potentiates salmonellosis in both cattle and swine [4,8].     
The protozoal receptors and cellular processes governing bacterial recognition, 
engulfment, and activation of the DT104 hyperinvasive phenotype are not well-characterized.  
This is partially due to the difficulty of maintaining rumen protozoa in axenic culture in addition 
to the fact that there are no genomic databases or tools available for these organisms.  On the 
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other hand, Tetrahymena thermophila is a widely utilized model ciliate that is a known predator 
of bacteria.  Tetrahymena is amenable to axenic culture and has readily available genomic 
database resources. Therefore, Tetrahymena may be a potentially useful model for the study of 
protozoal processes related to rumen protozoa-mediated Salmonella hypervirulence.   
 Protozoan predation of bacteria involves chemical detection of prey, followed by 
predator-prey interactions that initiate cytoskeletal rearrangement and subsequent 
phagocytosis [9].  Chemosensory feeding behavior may be driven by G protein-coupled 
receptors (GPCRs) which bind to bacterial components [10].  GPCR ligands can also have 
indirect stimulatory or inhibitory effects on phagocytosis in Tetrahymena [11,12].  Alternatively, 
ciliates such as Tetrahymena possess an oral groove where food items are swept 
indiscriminately [13].  Therefore, cyclic nucleotide binding proteins such as protein kinases may 
be more pertinent to the phagocytic process [14].  
 The present study was undertaken to assess the hyperinvasive behavior of Salmonella 
DT104 following engulfment by Tetrahymena.  In addition, RNAi-based studies were employed 
to identify protozoal genes related to bacterial engulfment and induction of the Salmonella 
hyperinvasive phenotype. 
 
MATERIALS AND METHODS 
Cell Cultures 
 Cell strains and plasmids used are summarized in Table 3.1.  Bacteria were stored in 
cryopreservation tubes containing 50% glycerol:50% culture medium at -70°C and grown in LB 
broth at 37°C with antibiotics such as ampicillin (50 µg/mL, Sigma), minocycline (50 µg/mL, 
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Sigma), and cefepime (50 µg/mL, Bristol-Myers Squib). Wild-type Tetrahymena thermophilia 
were obtained from ATCC and axenically grown in proteose peptone medium (5.0 g proteose 
peptone, 5.0 g tryptone, 0.2 g K2HPO4, 1 L distilled water) at 25
o
C.  Media was replaced every 
four days and cells were diluted 1:50 in fresh media.  HEp-2 cells were maintained in RPMI1640 
(Gibco) containing 10% fetal bovine serum at 37°C in a 5% CO2 humidified incubator. 
 
RNAi Experiments 
 Bovine rumen protozoa were obtained from a fistulated cow and total RNA was 
extracted using an RNA mini kit (Qiagen).  cDNA was then constructed by performing a RT-PCR 
reaction utilizing the Superscript One-Step RT-PCR kit (Qiagen) and random hexamers and polyT 
oligomers primers.  PCR products were cloned into pCRXL and sequenced by the Iowa State 
University DNA facility.  A BLAST analysis was conducted using GenBank to identify 
Tetrahymena homologs with a putative role in phagocytosis and three genes were selected.  
Two of the genes encode putative g protein-coupled receptors and the third encodes a putative 
cyclic nucleotide binding protein (XM_001021012.2, XM_001010055.2, and XM_001027519.2, 
respectively).  siRNA engineered to silence these genes was designed using the Invitrogen 
webportal.  The sequences CAGAAGTGCATTGAAGGAATA, TGGCTCAGTGTAAGTGACTTAATAT, 
and GCTGATTCATTTAATAGCCTTGCTT were deemed to be appropriate targets. 
 Tetrahymena were grown in 1 mL of media to a concentration of 10
4
 cells/mL and were 
harvested by centrifugation at 3,000xg for 10 min.  The pellet was washed twice, resuspended 
in 100µL, and transferred to a 0.2cm cuvette.  Cells were then electroporated (0.2 cm electrode 
gap, 10µF, 5 ms) with 0.5nM siRNA.  Post-transformation viability was assessed using trypan 
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blue staining 24 hours after electroporation. Transfected Tetrahmena were used in in vitro 
engulfment and invasion assays as well as an in vivo calf infection study. 
 Tetrahymena gene expression was assessed by RT-PCR following RNA extraction with 
the RNeasy minikit (Qiagen).  The number of cycles in the PCR portion of the reaction was 
varied to determine the number of cycles needed to produce a visible amplicon from wild-type 
and knock-down strains.  RT-PCR products were visualized on a 1.5% agarose gel using ethidium 
bromide staining. 
 
Engulfment and Invasion Assays 
 10
4
 siRNA-transfected Tetrahymena were co-incubated with 10
9
 CFUs Salmonella and 
gently rolled for 18 hr at room temperature.  To kill extracellular bacteria, 100µg/mL cefepime 
(Maxipime, Bristol-Myers Squib) was added and the mixture was rolled for 1 hr at room 
temperature.  Tetrahymena cells were lysed for 60 s at 4,800 RPM using 0.5 mm glass beads 
and a mini-beadbeater (Biospec products).  The lysate was centrifuged at 3,000 RPM for 2 min 
and resuspended in 300µL LB broth (Sigma).  100µL aliquots were plated on LB agar (Sigma) in 
triplicate for enumeration.    
 Tetrahymena and Salmonella were co-incubated as described above and the 
Salmonella-containing lysate was used in a HEp-2 cell invasion assay.  100µL aliquots of lysate 
were added in triplicate to cell culture wells containing approximately 10
5
 HEp-2 cells and 
incubated for 1 hr at 37ºC in a 5% CO2 humidified incubator.  Extracellular bacteria were then 
killed using 100µg/mL cefepime during a 1 hr incubation at 37
o
C in a 5% CO2 humidified 
incubator.  HEp-2 cells were lysed using 1% Triton X at 37
o
C and the lysate was plated on 
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selective media and grown overnight at 37
o
C.  Colonies were enumerated and percent invasion 
was calculated by dividing CFU recovered by CFU added. 
 
In vivo infection study 
 Salmonella were co-incubated with RNAi-transfected Tetrahymena as described above 
except that each strain was paired with a Salmonella DT104 isolate with a unique antibiogram 
(Table 3.1).  Neonatal Holstein calves (n=3) were orally inoculated with 9mL of a cocktail 
containing 3mL of each Salmonella-laden strain of Tetrahymena.  
 Animals were monitored for changes in appetite, stool consistency, and rectal 
temperature every 8 to 12 hrs.  At the onset of signs related to systemic salmonellosis, calves 
were euthanized with xylazine (0.5mg/Kg intramuscularly; Phoenix Laboratories) and 
pentobarbital (1.2mg/Kg, intravenously; Fort Dodge Laboratories).  Splenic samples, which are a 
reliable indicator of systemic burden, were collected following euthanasia. 
 Splenic tissue was aseptically cut into 0.1cm pieces, placed in an equal volume of PBS, 
and vortexed for 2 min.  Dilutions of the resulting homogenate were plated on BGA agar 
containing either ampicillin (50 µg/mL), minocycline (50 µg/mL), or cefepime (50 µg/mL) for 
enumeration.  Salmonella colonies were confirmed by PCR using primers specific for detection 
of the sipB-sipC gene fragment as described previously [15]. 
 
RESULTS  
 
Engulfment by Tetrahymena induces the hyperinvasive phenotype of DT104 
 Previous studies indicate that a variety of commensal rumen protozoa engulf, protect, 
and induce a hyperinvasive phenotype in Salmonella DT104.  We hypothesized that 
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Tetrahymena, a free-living ciliate, would also induce the hyperinvasive phenotype.  In the 
present student, Salmonella liberated from Tetrahymena were nearly 7 times more invasive in a 
HEp-2 cell invasion assay (Figure 3.1).  In support of these in vitro findings, oral inoculation of 
Holstein calves with Salmonella-laden Tetrahymena resulted in illness consistent with protozoa 
mediated hypervirulence (rapid onset of pyrexia, diarrhea, dehydration, depression; data not 
shown) and an increased systemic load of bacterial (Figure 3.2). 
 
RNAi inhibition of bacterial engulfment and protozoa-mediated hypervirulence in vitro 
 To determine if siRNA can interfere with expression of protozoal genes associated with 
bacterial engulfment, Tetrahymena were electroporated with siRNA and assayed for their 
ability to engulf Salmonella DT104.  Next, bacteria recovered from protozoa were evaluated for 
invasive behavior in a HEp-2 cell invasion assay [4,5].   
 Transfection of Tetrahymena with CNB1-targeting siRNA was associated with inhibition 
of bacterial engulfment by Tetrahymena and we observed a 5 fold decrease in the number of 
bacteria engulfed by the protozoan (Figure 3.3).  In addition, knockdown of CNB1 had an 
inhibitory effect on protozoa-mediated hypervirulence in vitro.  As shown in Figure 3.1, the 
invasive ability of Salmonella recovered from this line of knockdown protozoa was comparable 
to bacteria not exposed to protozoa.  Transfection of Tetrahymena with GPCR-targeting siRNA 
did not alter bacterial engulfment or protozoa-mediated hypervirulence.  RT-PCR revealed that 
electroporation with RNAi targeting CNB1 was successful (Figure 3.1) while RNAi targeting 
Tetrahymena G protein-coupled receptors was unsuccessful in achieving knockdown of gene 
expression (data not shown).    
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RNAi inhibition of protozoa-mediated hypervirulence in vivo 
 In vivo infection studies consisted of orally inoculating Holstein calves with Salmonella-
laden RNAi-transfected strains of Tetrahymena.  Each transfected strain contained a Salmonella 
isolate with a unique antibiogram and each calf received all three strains.  Thus, the relative 
virulence of bacteria originating from each Tetrahymena strain could be determined by 
comparing the systemic burden of Salmonella bearing a particular antibiogram.  
 At the time of necropsy, selective media containing antibiotics was used to isolate 
Salmonella from splenic tissue.  While Salmonella originating from two of the Tetrahymena 
strains was abundant (approximately 3x10
7
 CFU/gm spleen), Salmonella originating from CNB1-
knockdown Tetrahymena only accounted for approximately 0.03% of the total systemic burden 
(Figure 3.2).  All Salmonella isolates were confirmed by PCR amplification of the sipBC locus 
[15].   
 
DISCUSSION 
Previous studies in our laboratory have demonstrated that DT104 exhibits a 
hyperinvasive phenotype following engulfment by rumen protozoa [4-6].  The present study 
assessed the ability of Tetrahymena, a free-living ciliate, to mediate these changes.  In addition, 
we assessed the impact of siRNA on bacterial engulfment and the ability to induce the 
hyperinvasive phenotype of DT104. 
In vitro cell invasion assays and in vivo calf infection studies revealed that DT104 is 
hyperinvasive following engulfment by Tetrahymena.  Consistent with our previous studies, this 
phenomenon occurred in DT104 bearing SGI1 [4-6].  Tetrahymena and other free-living ciliates 
may represent an important reservoir for Salmonella and other intracellular pathogens.  While 
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some taxa of protozoa provide refuge for bacteria, some species preferentially predate and kill 
pathogenic bacteria [16].  Further research is needed to understand the significance of 
Salmonella and other pathogens harbored within environmental protozoa such as 
Tetrahymena. 
Protozoa require the ability to detect and engulf bacterial prey items in the 
environment.  However, the receptors mediating these feeding behaviors are not well known.  
In the present study, we electroporated Tetrahymena with siRNA targeting expression of 
putative GPCRs and Tet-CNB1, a putative cyclic nucleotide binding protein.  While we did not 
observe phenotypic effects associated with transfection with siRNA targeting G protein-coupled 
receptors, knockdown of CNB1 inhibited bacterial engulfment by Tetrahymena.  Interestingly, 
knockdown of CNB1 also ameliorated protozoa mediated Salmonella hypervirulence.  That is, 
these Tetrahymena were not capable of activating the hyperinvasive phenotype in vitro or in a 
calf model. 
The calf model in this study is novel and presents a platform for further studies 
investigating RPz-mediated salmonellosis.  Protozoa that were allowed to feed on DT104 with a 
unique antibiogram were orally inoculated into Holstein calves.  All calves received all 
Tetrahymena knockdown strains and we could then detect the relative systemic burden of 
DT104 originating from a particular Tetrahymena by growth on selective media.  This approach 
could be utilized to determine the relative contributions of different RPz genera to 
hypervirulence since it is unknown which RPz are the most significant inducers of the DT104 
hyperinvasive phenotype.     
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Cyclic nucleotide binding proteins have a variety of functions including their role as 
enzymes and transcription factors [17].  Since knockdown of Tet-CNB1 had effects on both 
engulfment and ability to invoke the hyperinvasive phenotype, it is possible that this is a 
transcription factor that regulates multiple systems within the cell.  Alternatively, TetCNB-1 
could be a kinase involved in intracellular vesicle trafficking.  The physiologic role of 
Tetrahymena cyclic nucleotide binding proteins, in particular TetCNB-1, is unclear at this point 
and warrants further investigation.  
Tetrahymena possesses the cellular machinery for RNAi and investigators have achieved 
knockdown of gene expression with hairpin structures [18].  Electroporation may offer a viable 
tool for delivery of dsRNA molecules.  In the present study, the decrease in mRNA levels of 
TetCNB-1 was transient, lasting approximately 1 week.  This is presumably because transfected 
and non-transfected cells were present in the cultures and after several matings normal gene 
expression returned.  Electroporation of individual cells may offer an option for generating 
Tetrahymena knockdown strains; however, this work is beyond the scope of the present study.  
Trypan blue staining assays and growth kinetic studies revealed that RNAi did not have an effect 
on the viability of the Tetrahymena cells (data not shown). 
 In summary, this study demonstrated that Salmonella DT104 bearing SGI1 are 
hyperinvasive following engulfment by Tetrahymena, a free-living ciliate. Electroporation of 
Tetrahymena with siRNA targeting the knockdown of Tet-CNB1, a cyclic nucleotide binding 
protein, perturbed both bacterial engulfment and the protozoan’s ability to invoke the 
hyperinvasive Salmonella phenotype.  Additional work is required to clarify the role of cyclic 
nucleotide binding proteins in Tetrahymena.  In conjunction with an RNAi-based approach, 
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Tetrahymena may provide a useful model for the study of protozoa-mediated Salmonella 
hypervirulence. 
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Table 3.1.  Summary of microbes and nucleic acids used in this study. 
Identity Details Reference/Comments 
   Salmonella typhimurium DT104 Hyperinvasive after exposure to protozoa Rasmussen et al., 2005 
Salmonella typhimurium TH11 Not hyperinvasive protozoa exposure Carlson et al., 1999 
Hep-2 Cells Mammalian cell line 
 pCRXL Confers zeocin resistance Commercially Available 
pMinocycline Confers minocycline resistance Xiong et al.,2011 
pCeftriaxone Confers ceftriaxone resistance McCuddin et al., 2006 
RNAi1 AUAUUAAGUCACUUACACUGAGCCA Targets GPCR 
RNAi2 GCUGAUUCAUUUAAUAGCCUUGCUU Targets GPCR 
RNAi3 CAGAAGTGCATTGAAGGAATA Targets Tet-CNB1 
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Figure 3.1.  Invasion of HEp-2 cells by Salmonella DT104 following engulfment by Tetrahymena.  
Tetrahymena were elecroporated with siRNA targeting G protein coupled receptors (RNAi1 and RNAi2) 
or TetCNB-1(CNBP).   The open bar represents the invasion of DT104 without any exposure to 
Tetrahymena.  Percent invasion is calculated by dividing the number of bacteria recovered from within 
cells by the number of bacteria added.  Data represented are the mean ± sem for three independent 
experiments performed in triplicate. *p<0.05 versus DT104 invasion in the absence of protozoa. 
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Figure 3.2.  Recovery of Salmonella DT104 from spleens of Holstein calves orally inoculated with 
bacteria-containing Tetrahymena.  Tetrahymena strains were electroporated with RNAi and paired with 
DT104 containing a unique antibiogram and all 3 calves received an equal amount of all three 
knockdown strains.  RNAi1 and 2 were designed to target GPCRs while RNAi4 targeted TetCNB-1.  Bars 
represent the average CFU/gram of spleen from each of three calves plated in triplicate. *p<0.05 versus 
other knockdown strains 
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Figure 3.3.  Engulfment of Salmonella DT104 by Tetrahymena.  Tetrahymena were elecroporated with 
siRNA targeting G protein-coupled receptors (RNAi1 and RNAi2) or TetCNB-1(CNBP).  Mock transfectants 
were electroporated without any siRNA.  Data represented are the mean ± sem for three independent 
experiments performed in triplicate.  Numbers above each bar represent the number of RT-PCR cycles 
needed to generate a visible amplicon for CNB-1. *p<0.05 versus mock transfected control. 
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ABSTRACT 
In an effort to investigate the molecular basis of protozoa engulfment-mediated hypervirulence 
of Salmonella in cattle, we evaluated protozoan G protein-coupled receptors (GPCRs) as 
transducers of Salmonella engulfment by the model protozoan Tetrahymena.  Our laboratory 
previously demonstrated that non-pathogenic protozoa (including Tetrahymena) engulf 
Salmonella and then exacerbate its virulence in cattle, but the mechanistic details of the 
phenomenon are not fully understood.  GPCRs were investigated since these receptors 
facilitate phagocytosis of particulates by Tetrahymena, and a GPCR apparently modulates 
bacterial engulfment for the pathogenic protozoan Entamoeba histolytica.  A database search 
identified three putative Tetrahymena GPCRs, based on sequence homologies and predicted 
transmembrane domains, that were the focus of this study.  Salmonella engulfment by 
Tetrahymena was assessed in the presence of suramin, a non-specific GPCR inhibitor.  
Salmonella engulfment was also assessed in Tetrahymena in which expression of putative 
GPCRs was knocked-down using RNAi.  A candidate GPCR was then expressed in a heterologous 
yeast expression system for further characterization.  Our results revealed that Tetrahymena 
were less efficient at engulfing Salmonella in the presence of suramin.  Engulfment was reduced 
concordantly with a reduction in the density of protozoa.  RNAi-based studies revealed that 
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knock-down of one the Tetrahymena GPCRs caused diminished engulfment of Salmonella.  
Tetrahymena lysates activated this receptor in the heterologous expression system.  These data 
demonstrate that the Tetrahymena receptor is a putative GPCR that facilitates bacterial 
engulfment by Tetrahymena.  Activation of the putative GPCR seemed to be related to 
protozoan cell density, suggesting that its cognate ligand is an intercellular signaling molecule.   
 
INTRODUCTION 
Protozoa engulf Salmonella and, while the bacteria reside inside the protozoa, host cell 
invasion capabilities are hyperactivated and the bacteria are hypervirulent after exiting the 
protozoa.  This protozoa-mediated hypervirulence occurs only for Salmonella strains bearing 
the multiresistance integron designated as SGI1, and its in vivo relevance has only been 
associated with protozoa that engulf Salmonella in the bovine rumen  [1-5].  Free-living 
protozoa, like Acanthamoeba and Tetrahymena, are models for studying this phenomenon [1-
5].  
Protozoal determinants of engulfment are unclear but Renaud et al. determined that G 
protein-coupled receptors (GPCRs) are apparently involved in Tetrahymena phagocytosis of 
particulates [6].  Furthermore, Picazzari et al. demonstrated that bacterial engulfment is 
governed by a GPCR in the pathogenic protozoan Entamoeba histolytica [6].  Additionally, 
Lampert et al. presented evidence for GPCR-encoding genes in the Tetrahymena database [6].  
The aim of this study was to assess the role of three putative GPCRs in the engulfment 
of Salmonella by Tetrahymena.  These three putative GPCRs were identified in a GenBank 
database search.  We used RNAi to preliminarily determine if any of these putative 
Tetrahymena GPCRs are involved in Salmonella engulfment.  A heterologous yeast expression 
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system was used to partially characterize one of these candidate Tetrahymena GPCRs.  Using 
these approaches we were able to identify a putative Tetrahymena GPCR involved in the 
engulfment of Salmonella.  
 
 
MATERIALS AND METHODS 
Tetrahymena culture 
 Tetrahymena thermophila was obtained from ATCC and axenically grown in the 
recommended ATCC medium (5.0 g/L proteose peptone, 5.0 g/L tryptone, and 0.2 g/L K2HPO4) 
at 25
o
C.  Media was replaced every four days and cells were diluted 1:14 in fresh media.  
 
Tetrahymena engulfment of Salmonella in the presence of suramin  
 Approximately 10
5
 to 10
9
 CFUs/mL of bacteria were added to approximately 10
1 
to 10
5 
Tetrahymena/mL, maintaining a multiplicity of infection equal to 10
4
.  The Salmonella-
Tetrahymena mixture was then gently rolled for 16 hrs at 37
o
C in a sealed 5 mL glass tube, in 
the presence of various concentrations of suramin (0-200µM)- a non-specific inhibitor of GPCRs 
(Freissmuth et al., 1999).  At the end of the 16-hr incubation period, extracellular Salmonella 
were killed using 300 µg/mL florfenicol [Schering-Plough; [4]].  Protozoa were then lysed for 60 
sec at 4,800 rpm using 2.5 mm glass beads and a mini-beadbeater (Biospec Products).  The 
lysate was centrifuged at 10,000 x g for 2 min, then resuspended in 350 µL Lennox L broth 
(Difco) that was plated on Salmonella-selective XLD agar plates (Fisher Scientific) and then 
incubated at 37
o
C overnight.  Characteristic black colonies were then counted the following 
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day.  Percent engulfment was calculated as such: 100x (number of Salmonella recovered from 
protozoa/number of Salmonella added to Tetrahymena). 
RNAi experiments  
 A preliminary GenBank database search identified three putative GPCR genes in 
Tetrahymena (XM_001009792.2, XM_001027519.2, and XM_001010055.2).  siRNA was 
designed, using the Invitrogen webportal (http://rnaidesigner.invitrogen.com/rnaiexpress), to 
silence expression of these three genes in Tetrahymena.  The sequences 
GAGATTACTACTAATAGCCTCTCTT, GCTGATTCATTTAATAGCCTTGCTT, and 
TGGCTCAGTGTAAGTGACTTAATAT were deemed to be appropriate siRNA targets for the three 
putative GPCRs, respectively.  A random sequence (CTGACGACAGTTGCATAAAGC) was used as a 
control siRNA.  Semi-quantitative RT-PCR (Carlson et al., 2007) was used to confirm the knock-
down of the genes encoding the putative GPCRs (Table 1). 
 Tetrahymena thermophila were grown in 5 mL of media to reach confluency (3 x 10
4
 
cells/mL), and were then harvested by centrifugation at 3,000 x g for 10 min.  The pellet was 
washed twice in 15 mL of deionized water and resuspended in 200 µL of deionized water.  
These cells were then electroporated (0.2cm electrode gap, 10µF, and 5 milliseconds) with 5nM 
siRNA. 
 At 24 hr after electroporation with siRNA, Tetrahymena cells were centrifuged at 4,000 x 
g for 5 min.  Tetrahymena were then spectrophotometrically enumerated and resuspended in 1 
mL of Luria-Bertani broth containing SGI1-bearing Salmonella at a multiplicity of infection equal 
to 10
4
.  After 1 hr of co-incubation, non-engulfed bacteria were then killed with florfenicol (300 
µg/mL) and protozoa were lysed with bead-beating.  Protozoal lysates were recovered and 
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plated on selective agar (XLD) for the enumeration of Salmonella engulfed by Tetrahymena, as 
described herein. 
Manipulation of the gene encoding the Tetrahymena GPCR 
 RNAi studies identified one of the putative GPCRs [XM_001009792.2] as a potential 
determinant of Salmonella engulfment.  In order to deorphanize this receptor in the yeast 
heterologous expression system, its gene was cloned into a yeast expression vector.  Since 
Tetrahymena genes have read-through stop codons encoding glutamine residues [7], the gene 
sequence encoding this GPCR was synthesized (GeneScript) whereby the 13 read-through stops 
codons (TAA or TAG) were exchanged for glutamine codons (CAA or CAG).  Codons were also 
optimized for expression in yeast. 
 
Construction and cloning of the yeast expression vector containing the Tetrahymena GPCR gene 
 The synthetic Tetrahymena GPCR gene was PCR-amplified with forward 
(5’GCCATACCATGGACCAATCATTTGGAAATCAA3’) and reverse (5’GCCATA-
GGATCCTCAAGTTAGATTTATTTCACGTGAAT3’) primers, which included filler sequences 
(underlined) and the restriction sites NcoI and BamHI (italicized) incorporated into the 5’ and 3’ 
ends of the amplicon, respectively.  Purified amplicons and the linearized yeast expression 
vector Cp4258, which bears a leucine prototrophic marker [8,9], were co-digested with NcoI 
and BamHI restriction endonucleases (New England BioLabs).  The digested vector and 
amplicons were ligated with T4 DNA ligase (New England BioLabs) and the resulting plasmids 
were transformed into Escherichia coli K12 and individual clones were selected in ampicillin 
(resistance encoded by the Cp4258 vector) and grown aerobically in LB broth overnight at 37
o
C.  
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Plasmid DNA was purified using the HiSpeed Plasmid Mini Kit (Qiagen) and inserts were verified 
using PCR and then sequenced to confirm gene orientation and fidelity. 
Transformation of yeast with the Cp4258/GPCR expression vector 
 Saccharomyces cerevisiae strain CY 19043 (J. Broach, Princeton University, USA) was 
used as the yeast recipient since these cells are leucine/histidine auxotrophs and exhibit a 
histidine prototrophic phenotype upon GPCR activation even if the receptor is exogenous [8,9].  
Non-transformed CY 19043 yeast were grown in YPD media supplemented with all essential 
amino acids.  Cells at mid-log phase (OD600 equal to 0.3 to 0.5) were co-incubated with 1 µg of 
Cp4258/GPCR construct, or Cp4258 bearing a non-Tetrahymena GPCR gene (an unpublished 
putative GPCR sequence from Cryptosporidium parvum), in the presence of 200 µg salmon 
sperm DNA (Invitrogen) and 0.1M LiAc (Sigma-Aldrich).  Yeast cells were then incubated at 30
o
C 
and then heat shocked at 42
o
C for 15 min.  Cells were plated on leucine-deficient media [1x YNB 
(Difco), 1x yeast synthetic dropout medium supplement without leucine (Sigma), 10 mM 
ammonium sulfate (Sigma), and 50% glucose] to select for transformation of Cp4258/GPCR.  
Transformants were verified by isolating plasmids (Promega Wizard Prep kit) and PCR-based 
detection of the Tetrahymena GPCR gene insert and its proper orientation.  
 
Partial deorphanization of the putative Tetrahymena GPCR using the yeast heterologous 
expression system 
A volume of 3 mL of leucine-deficient media was inoculated with yeast expressing the 
Tetrahymena GPCR, or the control, and grown at 30
o
C to an OD600 equal to one.  Cells were 
washed three times with leucine/histidine deficient medium [1x YNB (Difco), 1x yeast synthetic 
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drop out medium supplement lacking leucine and histidine (Sigma), 10 mM ammonium sulfate, 
50% glucose, 50 mM 4-morpholinepropanesulfonic acid, pH 6.8], and then resuspended in 1 mL 
leucine/histidine-deficient media to a density of 15–20 cells/µL.  Approximately 3,000 cells 
were added to each well of 96-well plates containing the same medium along with 50 µL of 
Tetrahymena culture media, Tetrahymena lysates (15–20 cells/µL lysed by bead-beating), or 
Tetrahymena lysates plus suramin (200 µM).  Cells were grown at 30oC for approximately 24 hr 
after which growth was measured spectrophotometrically at OD600.  Yeast cells transformed 
with the C. parvum GPCR-encoding vector were used as a control for each treatment.  
 
Statistical analysis 
 Statistical comparisons were made using ANOVA with Scheffe’s F test for multiple 
comparisons.  Comparisons were made across protozoal densities, suramin treatments, siRNA 
transformations, and yeast treatments.  GraphPad Prism 5.0 was the software used, with 
p<0.05 indicating statistical significance. 
 
Hydropathy analysis of the putative Tetrahymena GPCR 
 Since GPCRs are comprised of seven transmembrane domains, putative transmembrane 
domains were assessed using Kyte-Doolittle plots (Kyte and Doolittle, 1982) from a web-based 
platform (http://web.expasy.org/cgi-bin/protscale/protscale.pl).  Transmembrane signatures 
were ascribed to peptide regions in which hydropathy scores rose from negative values to 
values greater than one.  The codon-optimized deduced version of the protein, where 
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glutamine codons replace read-through amber (TAG) or ochre (TAA) stop codons, was used for 
the hydropathy analysis. 
RESULTS 
Suramin-mediated inhibition of the protozoa density-dependent engulfment of Salmonella by 
Tetrahymena  
In order to assess the possible role of a GPCR in the engulfment of Salmonella by 
Tetrahymena, we incubated Salmonella-Tetrahymena co-cultures with the non-specific GPCR 
inhibitor suramin.  As shown in Figure 4.1, bacterial engulfment increased with the density of 
Tetrahymena.  As shown in Figure 4.2, this engulfment was significantly hampered by suramin 
in a concentration-dependent manner at all Tetrahymena densities.   
 
RNAi-based screening of a GPCR involved in bacterial engulfment by Tetrahymena 
Our preliminary database query identified three Tetrahymena genes encoding putative 
GPCRs (XM_001009792.2, XM_001027519.2, and XM_001010055.2).  In order to assess the 
association of these GPCRs with bacterial engulfment, we knocked-down receptor expression 
with siRNA and then evaluated bacterial engulfment in Tetrahymena.  As shown in Figure 4.3, 
bacterial engulfment was significantly hampered in Tetrahymena electroporated with one of 
the siRNAs corresponding to the gene with GenBank accession number XM001009792.2.  
Expression of this receptor was diminished as verified by semi-quantitative RT-PCR, and no off-
target effects were noted in the transformants (Table 4.1). 
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Partial deorphanization of the putative Tetrahymena GPCR using Tetrahymena lysates and 
suramin  
Results presented in Figure 4.1 identified a putative GPCR involved in Salmonella 
engulfment by Tetrahymena.  In order to deorphanize this receptor, we expressed its codon-
optimized cDNA in a yeast heterologous expression system that exploits a histidine 
prototrophic phenotype upon GPCR activation by a cognate ligand [8,9].  We hypothesized that 
a Tetrahymena surface molecule activates the putative GPCR on neighboring Tetrahymena 
cells, thus we used Tetrahymena lysates as “ligands”.  We also assessed the activation of the 
putative GPCR in the presence of suramin, a non-specific GPCR inhibitor.  Treatment-control 
yeast were grown in leucine-deficient media in the absence of lysates or suramin.  
Transformation-control yeast were transformed with a vector encoding a non-Tetrahymena 
GPCR whose gene was cloned from C. parvum.  As shown in Figure 4.4, Tetrahymena lysates 
elicited significant increases in yeast growth in the transformants expressing the Tetrahymena 
GPCR.  This growth was blocked by the addition of suramin.  Tetrahymena lysates had no effect 
on yeast expressing the non-Tetrahymena GPCR cloned from C. parvum.  However, suramin was 
able to reduce the basal activity associated with this non-Tetrahymena GPCR. 
 
Secondary structure analysis of the putative Tetrahymena GPCR  
To assess the presence of motifs suggestive of a GPCR, a Kyte-Doolittle hydropathy plot 
(Kyte and Doolittle, 1982) was created for the putative Tetrahymena GPCR.  Figure 4.5 reveals 
that the putative Tetrahymena GPCR has the characteristic seven transmembrane domains. 
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DISCUSSION 
The objective of this study was to identify protozoal determinants involved in the 
engulfment of Salmonella, a phenomenon that hyperactivates the virulence of the bacteria [1-
5]. Protozoa enhance the virulence of SGI1-bearing Salmonella by hyperactivating the 
expression of the pro-invasion gene designated as hilA, and this hyperexpression leads to 
enhanced virulence when the bacteria escape from the protozoa.  The hyperactivation of hilA 
expression is dependent on the SGI1-specific gene designated as SO13 [2].  This phenomenon 
specifically occurs when SGI1-bearing Salmonella are engulfed by and then are liberated from 
free-living protozoa, such as Acanthamoeba and Tetrahymena [2], or from host-associated 
protozoa [1-5].  The protozoa/SGI1-bearing Salmonella hypervirulence relationship appears to 
be relevant to the ingestion of water contaminated with free-living protozoa harboring SGI1-
bearing Salmonella [5], and cattle that naturally harbor large numbers of protozoa in their 
rumen [1-5]. 
GPCRs were the focus of the present study since these receptors are apparently 
involved in Tetrahymena phagocytosis of particulates [6], and another group presented 
evidence for GPCR-encoding genes in the Tetrahymena database [10].  Additionally, a GPCR was 
implicated in the engulfment of bacteria by the pathogenic protozoan Entamoeba histolytica 
[11].  In the present study we provide evidence that a putative GPCR governs Salmonella 
engulfment by Tetrahymena.  It also appears that this engulfment process is dependent upon 
the density of protozoa, suggesting intercellular communication by Tetrahymena. 
It appears that a specific seven transmembrane-spanning protein mediates the 
engulfment of Salmonella.  This protein is putatively a GPCR given its ability to stimulate 
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histidine prototrophism in a yeast heterologous expression in which G proteins govern de novo 
synthesis of histidine following ligand occupancy of a GPCR.  Histidine prototrophism was 
observed in the presence of Tetrahymena lysates while suramin was able to block the histidine 
prototrophism in the presence of Tetrahymena lysates, further indicating that the protein is a 
GPCR.  Suramin has some unknown effects, but we found that this molecule inhibited the 
Tetrahymena GPCR in two disparate systems.  Additionally, suramin reduced the basal activity 
of a non-Tetrahymena GPCR in the yeast system.  Because of the unknown effects of suramin, 
however, we are unable to completely rule out GPCR-independent mechanisms contributing to 
its effects on Tetrahymena and the yeast. 
Since Tetrahymena lysates activated the putative GPCR, an unknown Tetrahymena 
factor(s) appears to be an autocrine-like ligand for this receptor.  This factor may be 
membrane-associated, whereby the receptor could be constitutively activated due to continual 
ligand occupancy when Tetrahymena are confluent.  Alternatively, this may be a secreted 
factor.  Although Tetrahymena has been established as an important model protozoan, there is 
little information on GPCRs in this organism except for a recent study [10].  Interestingly, there 
has been debate regarding the existence of Tetrahymena GPCRs [12]. 
In conclusion, we determined that a putative Tetrahymena GPCR is responsible for the 
engulfment of Salmonella by the protozoan.  We also partially characterized this unique 
receptor that appears to be activated by intercellular ligands whose threshold appears to be 
dependent upon the density of protozoa.   
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TABLE 4.1.  Semi-quantitative RT-PCR of GPCR targets in Tetrahymena transformed with siRNA.  
DNA-free RNA was isolated and subjected to an RT-PCR assay that semi-quantitates transcript 
levels based on the number of PCR cycles required for amplicon visualization using agarose gel 
electrophoresis. 
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Figure 4.1.  Salmonella engulfment at various densities of Tetrahymena.  For each density of 
protozoa, Salmonella and Tetrahymena were co-cultured using a multiplicity of infection equal 
to 10,000.  Bacterial engulfment (average number of bacteria per protozoa) was determined 
after lysing protozoa.  Each data point represents the mean ± sem for three independent 
experiments performed in triplicate.  *p<0.05 versus the rest of the data. 
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Figure 4.2.  Salmonella engulfment by Tetrahymena exposed to suramin.  For each concentation 
of suramin, Salmonella and Tetrahymena were co-cultured using an MOI equal to 10,000.  
Bacterial engulfment was determined after lysing protozoa.  Each data point represents the 
mean ± SEM three independent experiments performed in triplicate. * p< 0.05 versus the 
results of suramin-free assays. 
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Figure 4.3.   Salmonella engulfment by Tetrahymena electroporated with RNAi corresponding to 
putative GPCR genes.  A preliminary database search identified three putative GPCR-encoding 
genes (GenBank accession numbers provided in the x-axis) in Tetrahymena and siRNA was 
designed based on these sequences.  Bacterial engulfment (average number of bacteria 
engulfed per cell) was determined after electroporation with siRNAs.  Random RNAi and mock 
transformants served as controls.  Data presented are the mean + sem for three independent 
experiments each performed in triplicate.  *p<0.05 versus the rest of the data.  
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Figure 4.4. Tetrahymena lysate-mediated activation of histidine prototrophism in yeast 
expressing the Tetrahymena GPCR.  Yeast transformants were exposed to the lysates and yeast 
growth was measured spectrophotometrically at OD600.  To determine background growth, 
yeast transformants were grown in media lacking leucine and histidine (untreated control).  As 
an additional control, yeast cells were transformed with a vector encoding an unrelated GPCR 
(from C. parvum) and then grown in the same conditions.  Growth is quantitated as compared 
to growth observed in untreated controls.  Suramin, when used, was added at 200µM  Data 
presented are the mean + sem for three independent experiments each performed in triplicate.  
*p<0.05 versus untreated controls. 
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Figure 4.5. Kyte-Doolittle hydropathy plot of the putative Tetrahymena GPCR.  Putative 
transmembrane domains were assessed using Kyte-Doolittle plots (Kyte and Doolittle, 1982) 
from a web-based platform (http://web.expasy.org/cgi-bin/protscale/protscale.pl).  
Transmembrane signatures were ascribed to peptide regions in which hydropathy scores rose 
from negative values to values greater than one.  Putative transmembrane regions are 
indicated numerically from one to seven. 
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CHAPTER 5.  EVIDENCE FOR A BACTERIAL LIPOPOLYSACCHARIDE-RECOGNIZING RECEPTOR IN 
THE BACTERIAL ENGULFMENT BY ENTAMOEBA HISTOLYTICA 
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ABSTRACT 
Entamoeba histolytica is the causative agent of amebic dysentery, a worldwide protozoal 
disease that results in approximately 100,000 deaths annually.  The virulence of E. histolytica 
may be due to interactions with host bacterial flora whereby trophozoites engulf colonic 
bacteria as a nutrient source.  The engulfment process depends on trophozoite recognition of 
bacterial epitopes that activate phagocytosis pathways.  EhGPCR-1 was previously recognized 
as a putative G protein-coupled receptor (GPCR) used by Entamoeba histolytica during 
phagocytosis.  In the present study, we attempted to characterize EhGPCR-1 using heterologous 
GPCR expression in yeast.  We discovered that bacterial lipopolysaccharide (LPS) is an activator 
of EhGPCR-1, and that LPS stimulates EhGPCR-1 in a concentration-dependent manner.  
Additionally, we demonstrated that Entamoeba histolytica prefers to engulf bacteria with intact 
LPS and that this engulfment process is sensitive to suramin, which prevents interaction of 
GPCRs and G proteins.  Thus, EhGPCR-1 is an LPS-recognizing GPCR that is a potentially 
druggable target for treating amebiasis, especially considering the well-established druggability 
of GPCRs. 
 
INTRODUCTION 
 
Entamoeba histolytica is an important cause of amebic dysentery [1].  E. histolytica 
infection often manifests as colitis but trophozoites can also gain access to the systemic 
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circulation resulting in liver or brain abscesses [2,3].  The majority of infections are 
asymptomatic [4] and many of the host factors determining the pathologic severity of infection 
have not been well characterized.   
The virulence of E. histolytica may be due to interactions with host bacterial flora.  Co-
culture with bacteria can restore amoebic virulence in E. histolytica cell lines attenuated 
through serial passage [5,6], and this effect is related to an upregulation of genes associated 
with enhanced phagocytosis [7].  Specifically, E. histolytica exhibits enhanced adherence and 
cytotoxic abilities following engulfment of enteropathogenic bacteria [8].  E. histolytica is also 
dependent on colonic bacteria as a nutrient source for trophozoites.  Prior to the advent of 
selective medium, trophozoites could only be grown in culture medium containing bacteria [9].  
Although trophozoites are now routinely grown in bacteria-free culture medium, exposure to E. 
coli enhances their growth [8].  However, while it is clear that E. histolytica regularly engulf 
bacteria, the specific bacterial epitopes recognized by amoebic receptors are unknown. 
Phagocytosis is a stepwise process that is initiated by activation of receptors that bind 
an extracellular target and ultimately activate cytoskeletal rearrangements.  Phagocytic ability 
is essential for the pathogenesis of amebiasis and is strongly correlated with virulence; E. 
dispar, a non-pathogenic species, is less efficient at engulfing bacteria [10,11].  While many 
studies have established the importance of phagocytosis in amoebic pathogenesis, relatively 
few receptors mediating this process have been identified.  Transmembrane kinase TMK96 is 
involved in erythrophagocytosis, while TMK39 is a cholesterol receptor that may also mediate 
bacterial engulfment [12,13].  In phagocytes of metazoa, G protein-coupled receptors (GPCRs) 
have been found to initiate the phagocytosis of bacteria [14].  GPCRs are transmembrane 
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receptors that act as guanine nucleotide exchange factors upon binding extracellular ligands.  
Recent studies by Bosch et al. described G protein signaling in E. histolytica, however, the 
receptors interacting with amoebic G proteins are not well established [15].  Picazarri et al. 
described EhGPCR-1, a putative GPCR associated with vesicular trafficking of proteins that 
localize to phagocytic cups [16].  EhGPCR-1 is highly expressed in pathogenic E. histolytica but 
not in E. dispar (www.amoebadb.org version 2.0), possibly accounting for the differential 
engulfment of bacteria by these divergent Entamoeba species [17].  The ligand for EhGPCR-1 
had not been identified prior to the present study.  
We hypothesized that since EhGPCR-1 has a putative role in the initiation of 
phagocytosis, it may recognize bacterial prey that are an essential nutrient source and 
potentiators of virulence for E. histolytica.  In the present study, we used a heterologous yeast 
expression system to screen bacterial components for their ability to activate EhGPCR-1.  In 
addition, we tested the ability of E. histolytica trophozoites to selectively engulf bacteria based 
on the presence of a bacterial component putatively identified as a ligand for EhGPCR-1.  
 
MATERIALS AND METHODS 
 
Creation of the yeast expression vector encoding EhGPCR-1   
 DNA encoding EhGPCR-1 (accession number AY880672) was synthesized by GeneScript 
using codon optimization for yeast expression.  The gene was cloned into the pUC57 vector and 
the cDNA was amplified with forward and reverse primers adding the restriction sites NcoI and 
BamHI (5’GCCATACCATGGATCAATCATTCGGTAATCAA3’) and (5’GCCATAGGATCCTTAA-
GTCAAGTTAATTTCTCTTGAA3’) to the 5’ and 3’ ends of the amplicon, respectively.  Purified 
amplicons and the linearized yeast expression vector Cp4258, which contains a leucine 
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auxotrophic marker and encodes for ampicillin resistance [18,19], were co-digested with NcoI 
and BamHI restriction endonucleases.  The EhGPCR-1 gene was then ligated into Cp4258 using 
T4 DNA ligase (New England Biolabs).  The resulting plasmid was transformed into E. coli and 
individual clones were selected and aerobically grown overnight at 37
o
C in Luria-Bertani (LB) 
broth containing 32µg/mL ampicillin.  Plasmid DNA was purified using HiSpeed Plasmid Mini Kit 
(Qiagen) and inserts were sequenced to confirm cDNA orientation and fidelity. 
 
Transfection of yeast with the EhGPCR-1 expression vector    
 Saccharomyces cerevisiae strain CY 18043 (J. Broach, Princeton University, USA) was 
used as the yeast recipient since this strain is a histidine auxotroph that exhibits histidine 
prototrophism upon GPCR activation even for exogenous receptors [18,19].  Non-transfected 
CY 18043 yeast were grown in YPD media supplemented with all essential amino acids.  Cells at 
mid-log phase (OD600 equals 0.3 to 0.5) were transfected with 1µg cDNA construct or 1 µg 
empty vector (mock-transfectants) in the presence of 200µg salmon sperm DNA (Invitrogen) 
and lithium acetate (100mM, Sigma-Aldrich).  Yeast cells were then incubated at 30
o
C and heat 
shocked at 42
o
C for 15 min.  Cells were placed on leucine-deficient media [1x YNB (Difco), 1x 
yeast synthetic drop-out medium supplement without leucine (Sigma), 10 mM ammonium 
sulfate (Sigma), and 50% glucose] to select for transfection of Cp4258 with the EhGPCR-1-
encoding plasmid.  Transfectants were verified by isolating plasmids (Promega) and colonies 
expressing the EhGPCR-1 were verified by PCR prior to the functional assay. 
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Yeast Growth Assay   
Since the Cp4258 vector encodes for leucine prototrophism, leucine-deficient media 
was inoculated with yeast expressing EhGPCR-1 or mock-transfected yeast that were grown at 
30
o
C to an OD600 equal to one.  Cells were washed three times with leucine/histidine deficient 
medium [1x YNB (Difco), 1x yeast synthetic drop-out medium supplement lacking leucine and 
histidine (Sigma), 10 mM ammonium sulfate (Sigma), 50% glucose, 50 mM 4-
morpholinepropanesulfonic acid, pH 6.8] and resuspended in 1mL leucine/histidine-deficient 
media, to a density of 15–20 cells/µL.  Approximately 3,000 cells were added to each well of 96-
well plates containing the same medium along with test agonists in a total volume of 200µL.  
Cells were grown at 30
o
C for approximately 24 h.  Initial and final OD600 values were measured 
with a spectrophotometer to determine growth of the yeast. 
 
Agonist and Antibody Binding Studies   
 E. coli (K12 strain, Sigma-Aldrich) and LPS-free rough strain E. coli MG1655 (K12 
derivative, N. Cornick, Iowa State University, USA) were grown aerobically overnight in LB broth 
at 37
o
C.  To produce bacterial lysates, cultures were incubated for 10 min at 100
o
C.  Purified 
lipopolysaccharide (LPS) from E. coli 0111:B4 (Sigma-Aldrich) was also used as a test agonist. 
Serial dilutions of whole bacteria, lysate, or LPS were added to leucine/histidine-
deficient media for use in the yeast growth assay.  Antibody-mediated inhibition of GPCR 
activation was performed by co-incubating test agonists in 200µL media with 25µL equine anti-
LPS antiserum (MG Biologics, Ames, IA; 1:10 titer) in the absence or presence of proteinase K 
(Qiagen, 50µg/mL, 3 h, 37oC).    
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Bacterial Engulfment Assay   
Bacteria were fluorescently labeled by growing 8x10
8
 CFUs in 1 mL of LB broth 
(Invitrogen) containing 10μg FITC (Sigma-Aldrich).  Cells were washed three times with and 
were resuspended in M199 medium (Gibco) supplemented with 25mM HEPES and 5.7mM 
cysteine (M199s). 
E. histolytica HM1 trophozoites (courtesy of Dr. William Petri, University of Virginia) 
were grown under anaerobic conditions at 37ºC in TYI Medium [9].  Trophozoites were 
harvested by centrifuging for 5 min at 1,000 RPM and 2.5x10
5
 trophozoites were added to each 
well of a 24-well tissue culture dish in 500µL of TYI medium.  Cells were allowed to adhere to 
the wells for 1 h at 37ºC under anaerobic conditions.  For engulfment inhibition experiments, 
trophozoites were allowed to adhere and then were incubated with suramin (Sigma-Aldrich) for 
1 hour.  Each well was washed twice with pre-warmed M199s medium and inoculated with 
8.75x10
6
 CFUs bacteria in a final volume of 500µL of M199s medium.  Bacteria and amoebae 
were co-incubated at 37ºC for 25 min in the presence or absence of suramin.  The medium was 
aspirated and 500µL ice-cold 110 mM D-galactose was added to each well to detach 
trophozoites.  Cells were pelleted by centrifuging for 5 min at 1,000rpm and washed with 500µL 
ice-cold 110 mM D-galactose.  Cells were then fixed in 2% paraformaldehyde for 20 min at 
37ºC.  Paraformaldehyde was neutralized with 50mM ammonium chloride, and cells were 
pelleted and resuspended in phosphate-buffered saline.  Aliquots (5µL) were fixed with 
Fluoromount-G mounting medium (Southern Biotech; Birmingham, AL) on a microscope slide.  
These specimens were examined by fluorescence microscopy on an Olympus BX51 microscope 
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with a UPlan F1 40x/0.75 objective equipped with an HBO lamp and dichroic FITC illumination 
filter for visualization of bacterial engulfment by trophozoites. 
For flow cytometry experiments, at least 10,000 amoebic cells were analyzed for the 
presence of internalized bacteria on a Becton Dickinson FACScalibur or a Miltenyi MACSQuant 
(excitation wavelength of 488nm).  Data was acquired using CellQuest Software (BD 
Biosciences) or MACSQuant software (Miltenyi Biotech) and analyzed by FlowJo Flow 
Cytometry Analysis software (Tree Star, Inc., Ashland, OR). 
 
Search for Other GPCRs in E. histolytica   
Using our GPCR search algorithm designated as transmembrane-focused support vector 
machine (TMf-SVM), we explored the E. histolytica genome for GPCR-like sequences as 
previously described for other eukaryotes (20).  Expression of these sequences was then 
searched in the Entamoeba database (www.amoebadb.org version 2.0), using data from 
expressed-sequence tags and microarrays. 
 
Statistical Analyses   
Statistical analyses were performed using an analysis of variance with Scheffe’s F test for 
multiple comparisons.  StatView was used as the software. 
 
RESULTS 
 
EhGPCR-1 activation by bacterial lysate   
To determine if EhGPCR-1 recognizes bacterial components, we monitored the response 
of the receptor to bacterial lysates using a histidine auxotrophic yeast heterologous expression 
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assay [18,19].  In this assay, the GPCR of interest is expressed in histidine auxotrophic S. 
cerevisiae engineered to lack their native GPCRs.  When the expressed GPCR of interest is 
stimulated by its cognate ligand or agonist, a promiscuous GPCR-inducible pheromone pathway 
is activated which leads to the downstream expression of the His3 reporter gene.  His3 encodes 
for de novo histidine synthesis enzymes, and thus His3 expression provides the ability to grow 
on histidine-deficient media.  As a result, heterologous receptor activation can by quantified by 
spectrophotometric analysis of yeast growth.  Receptor activation is calculated as ligand-
induced yeast growth compared to growth of yeast transfected with empty vector and exposed 
to the same ligand or agonist.  
Application of E. coli K12 lysates to EhGPCR-1-expressing yeast produced significant 
increase in yeast growth; specifically, the EhGPCR-1-expressing yeast were stimulated more 
than 1400% compared to mock-transfected yeast (Figure 5.1).  This growth was markedly 
attenuated by the addition of anti-LPS antibodies and the effect of the anti-LPS antibodies was 
abrogated by proteinase K.  Addition of a rough strain of E. coli K12, which lacks the outer O-
antigen of LPS [20], stimulated EhGPCR-1 to a significantly lesser extent.  Histidine 
prototrophism was not observed when EhGPCR-1 expressing yeast were exposed to a panel of 
biogenic amines (histamine, serotonin, dopamine, epinephrine, and norepinephrine, 0-100mM) 
that are classic GPCR agonists or antagonists in mammals (data not shown).  Specifically, these 
biogenic amines were used in early deorphanization attempts since they are important GPCR 
ligands in a variety of organisms. 
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Concentration-dependent activation of EhGPCR-1 by LPS   
Since EhGPCR-1 was putatively activated by LPS, we examined the ability of LPS to 
stimulate EhGPCR-1 in a concentration-dependent manner.  EhGPCR-1-expressing yeast were 
incubated with various concentrations of purified LPS isolated from E. coli 0111:B4 and, again, 
yeast growth in histidine-free medium was measured as an indicator of EhGPCR-1 activation.  
LPS activated EhGPCR-1 in a concentration-dependent manner with an EC50 of 15 nM (Figure 
5.2).   
 
Preferential engulfment of LPS-expressing E. coli by Entamoeba histolytica trophozoites   
To determine if E. histolytica trophozoites selectively engulf bacteria based on the 
presence of LPS, we compared the engulfment of E. coli K12 and a rough isostrain of E. coli that 
lacks intact LPS.  Bacteria were fluorescently labeled with FITC and co-incubated with E. 
histolytica HM1 trophozoites.  Trophozoites were washed to remove bacteria that were not 
engulfed or attached and the number of E. histolytica trophozoites containing bacteria was 
quantitated by flow cytometry.  Phagocytosis assays revealed that 23.2% of trophozoites 
contained E. coli K12 while only 3.8% of trophozoites engulfed the rough strain.  This represents 
a  >80% reduction in the bacterial engulfment capability of E. histolytica (Figure 5.3).  Because 
no EhGPCR-1-specific drugs are known, we confirmed the role of G protein signaling in bacteria 
engulfment by conducting phagocytosis assays in the presence of suramin which uncouples 
GPCR and G proteins [21].  Suramin blocked phagocytosis in a concentration-dependent 
manner with an IC50 of approximately 80µM (Figure 5.4). 
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Identification of GPCR-like sequences in the E. histolytica genome   
In order to assess the potential role of other GPCRs in the suramin-mediated effects on 
bacteria phagocytosis, we investigated the possible existence of other E. histolytica GPCRs.  
Using a search algorithm that mines occult GPCR-encoding sequences from non-mammalian 
genomes by targeting transmembrane signatures [20], we uncovered eight sequences encoding 
putative GPCRs.  As summarized in Table 5.1, EST and microarray studies (www.amoebadb.org) 
revealed that none of these receptors appear to be expressed in E. histolytica.  EhGPCR-1 is 
expressed in E. histolytica, but not in E. dispar.  
 
DISCUSSION 
 
Previous work indicated that EhGPCR-1 is linked to phagocytic pathways in E. histolytica 
[16].  The goal of the present study was to characterize EhGPCR-1 by determining its cognate 
ligand in a heterologous expression system, and to confirm the functional activity of the ligand 
in E. histolytica trophozoites. 
GPCRs are cell surface receptors that sense the extracellular environment and are 
activated by a variety of ligands such as catecholamines, peptides, lipids, carbohydrates, etc. 
GPCRs are excellent drug targets, reflected by the fact that 30-50% of currently marketed drugs 
target these receptors [22,23].  While GPCRs have been well studied in vertebrates, the study of 
their role in E. histolytica physiology is only in its infancy.  E. histolytica express heterotrimeric G 
proteins which have been shown to modulate pathogenic processes, yet few receptors 
interacting with these G proteins have been identified [15].  A review by Bosch and Siderovski 
indicated that E. histolytica G proteins lack homology to mammalian G proteins [24], suggesting 
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that GPCRs have not been identified in E. histolytica because of inadequacies in genomic search 
tools for divergent receptors.  Classic GPCR agonists such as histamine and serotonin can 
modulate E. histolytica phagocytosis and virulence in a mouse model, but their receptors 
remain unidentified [25,26].  EhGPCR-1 did not respond to these ligands in our yeast assay 
(data not shown).  Furthermore, our genomic search tool did not uncover any other GPCRs 
expressed by E. histolytica (Table 5.1).  In the absence of another GPCR expressed by E. 
histolytica (that could be targeted as a control that rules out collateral effects) and our 
inexperience with hairpin RNA, we were unable to perform the appropriate control 
experiments using RNAi-based knockdown of EhGPCR-1 expression.  
The present study utilized a novel yeast auxotroph assay for screening GPCRs against 
potential ligands and agonists.  This approach has recently been applied to GPCRs from parasitic 
helminths [18,19], and may represent a valuable tool for the study of protozoan receptors since 
culture of these microbes is often difficult.  Utilizing this approach, we demonstrated that 
EhGPCR-1 is activated by a bacterial component of E. coli.  This activation was abrogated in the 
presence of anti-LPS antibodies or a generic GPCR inhibitor.  Purified LPS induced 
concentration-dependent EhGPCR-1 activation although this response was not as robust as the 
response to bacterial lysates.  Structural variances between LPS from E. coli K12 and E. coli 
0111:B4 might explain differences in receptor activation.  Alternatively, additional bacterial 
components may be required for maximal occupancy of EhGPCR-1.  Further research is needed 
to unveil the unique pharmacologic aspects of EhGPCR-1 in E. histolytica with respect to agonist 
affinity and binding cooperativity.  EhGPCR-1 may represent a new GPCR subtype since an NCBI 
motif database search revealed that it is most related to the MIG-14-Wnt-bd superfamily of 
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proteins, and it lacks the E/DRY and NPXXY motifs found in class A types of GPCRs (29).  
Interestingly, one of the non-expressed E. histolytica GPCRs contains a DRY motif (Table 1). 
Based on the results of our yeast expression assay, we hypothesized that E. histolytica 
initiates bacterial engulfment after recognizing bacterial LPS.  Phagocytosis assays 
demonstrated a  >80% reduction in the number of trophozoites containing bacteria when the 
bacterial prey lacked O-antigen, the outermost layer of the LPS.  This result is supported by 
previous research indicating that E. histolytica primarily engulfs Gram-negative pathogens [27].   
Other investigators have also demonstrated selective engulfment of bacteria by amoebae 
based upon bacterial O-antigen [28,29].  Therefore, other taxa of protozoa potentially express 
similar receptors for bacterial recognition.  EhGPCR-1 mediated preferential bacterial feeding 
behavior may also lead to disruptions in intestinal microbiota which is observed during 
infection with E. histolytica [30].  Composition of intestinal flora is likely to be a factor allowing 
E. histolytica colonization of the gut, and the role of EhGPCR-1 in this process is a current line of 
research in our laboratory.   
In summary, this study demonstrates the utility of a heterologous yeast expression 
system in the characterization of EhGPCR-1, a GPCR putatively used in phagocytosis by 
pathogenic E. histolytica.  EhGPCR-1 is activated by bacterial LPS, suggesting that this GPCR may 
be used to initiate phagocytosis upon the recognition of bacterial prey.  Functional studies 
supported the role of LPS in engulfment of E. coli by E. histolytica.  EhGPCR-1 is the first GPCR to 
be characterized in E. histolytica and it may represent an important chemotherapeutic target in 
this pathogen.    While this may be the only GPCR expressed in E. histolytica despite the 
unexplained presence of non-expressed GPCR-encoding genes, other protozoan GPCRs may 
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represent innovative drug targets, and their roles in regulating protozoan physiology merits 
further investigation.  
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Table 5.1.  Identity of eight putative and novel E. histolytica GPCRs uncovered using TMf-SVM 
(20).  Expression of each receptor is also listed, as determined from EST and microarray results 
at www.amoebadb.org.  EhGPCR-1 is presented in the last row.  The DRY motif (29) is bolded 
and underlined in the sequence for XP_657521.1/EDI_148210. 
Accession 
number and 
amoeba database 
number, 
respectively 
Deduced amino acid sequence Expressio
n in E. 
histolytica 
XP_648517.1 
EDI_139040 
MQSLAQTKTVLLTSLSPKGFSSIFIGFLMAVSFVMIMTMSLPTQYGTKTLNNTCAFSDSSACLSHLVQNGS 
NFTVKVDDIAATNQKVYIYLTYELQNAPRGRIKMSVNTALYKPKEKNKSITKYDEVKLIKSFTKKHRSFCN 
SNNSCEVLLASIESSKQYEDIYAVFSVNSVSLSESLGSPSLSIVYITPEFTSFEVFWRITLLTSMCCCTLF 
FMYVLRGIPFKQWSLEQKCTVLFMIALTISNNGFYSYEFMSANELFPSINAICDSIMLCSLLLYVLVVMDA 
LRKPLSQRTFKFFYFPRFLIVLLIGSFLVNLYLYNAENSDPVIVMMKDPINATMAILTGLLSLIYLFWLMF 
AIIRSFSEARKLGEKGQRIKMYGTFTIIAIFIFFVLLLSDYFIGYRSNAAVYLTLIAYVNIYAVVLMIFYL 
PSTKNQNEWNNRRREIVLDDVKVTQYDDDDNELVVEENNEKNEAEILIAATNEEPTGDIDSKKIEL 
No 
XP_654063.1 
EDI_137920 
MEITQPEKKKLGILMNTISLKGILAIAMIFILITGAITIIAIISPKPYIQTKVGLWECSQSTQTFNPNICK 
GWDSYSTLTSPSTDKNISTSIVVGPFATLNKDVTFGLLLKNVFTSSNMPSFSFKLNLEYSFQPFNDIKLVS 
TVNYVREVAQNINVECTNGNEFCNVDFSVFKRFGTLTYERFDIFSLSSSSLEKMDQAEFYGTIQTSNSSST 
VFEIYWRICLAFGNCVLLCLFFWFLRLYSVFNWALEQHLTALLIYGLILFNNPFCLLEHITGASFFLMVDS 
FFESFFTGYLMFYILAVFNSVRRPERAKGFIPLIVRAIMAIIISCSAFGSILSIRMTIQSNSKFHSNTLTI 
FFSVMFLLSIVIYLFWLLFEVIRSFSERRKMSGSNKNRVVIFGIVTFGCIFLLMAVYVGVYFSGYMVSNMF 
IGLLAYVNLYCFFVAILNLPSLQKQGSNTNGVNIAKLDTEFKVETYDDDDELVVENKNEEGTLEDSVALN 
No 
XP_652949.1 
EDI_025380 
MNVSNKDIYLKSKLVKDQDNSFAGFVLLPSEYSFNDICILTKNGQLSDISSKGYVFFQLKTQSTYINVKKG 
TYRLVYFSCGNKKIKWVNAKIIQGYTKDGIYHYLSSGEYPMIMITEIFGFILLVVILYDLYLLYKRETHTV 
QTLITGFSIIIFLHLCFDVLTLKATDSKGISNIRYFDYTFRIIETLSFYIVTLLVASGWSRKSKFSFEQKK 
TLLFFILLQVLSNVLYLVAEENELVNTRVTSVLRLIDIICSICILFPLIKTLNLLKKNTGTEAKTLKQYQR 
FSRCYSILLTIAYVKILLAYINDIASTREFDFIYLSVDKSLYIIYSIYLMIAFRPKKIISSSDEPKELMTE 
NTFDETKQEISKNTKNYQPEVSLNSFPTETSQNEEIKSVVLLDNNEHQEDTLSTTHNKNDICVELE 
No 
XP_651967.2 
EDI_039820 
MGIFDNKQTLLSSLDRKGLIIIGVIFSVLAVLLSILATVFTSTVIENSMDLWRCNNTEKFDSKQCMGYNAF 
NKEKEAIQYDKVKVHFGYFSRFNYEARISLSAEIKSEELTTQKTFIVPIHYFLGGYSDEEAMKNVDPELTE 
TMNINFECSQKSCKSDFLLKFKADYHFYYFIFQTDNSYKDEIIMKPTLTLMTSNSFFTVTELFWRIAFVCV 
GSIQLMTFMYCMRTIPIKEWIFEQILTFTLMYILLLFNNPLALIEYQAHHWFFSLISSVVESFAISFFLFY 
ILIIFDSLRKPINKMSTTTLWFKFIGVRVIFVGIIFITLCCFIFTQKVFDIKYLIAGTSNVVLIILGVIVL 
LIVLTYAFWLIFSLIRTFTERHKLGEKSRRVIGFSVFNIVIVFIFIIVLSILLFDGYDASSIYLASIVYFN 
LYCFAMALLMVKNDKQELSRRSKKFEISHPTEVSMEVNEYNDDDEIIIKEQPEEGILVDEQISL 
No 
XP_657521.1 
EDI_148210 
MESEIQLAHFRKIHYIVMTIFLILFFLFTIILGIFGPSEYSLKTQSGFKSVEGDGFQFTLPVLNKNELELK 
VMYQQKININNNYNMTIYEKKSQAIEVNFIDKDDKINETKIFNFTCTYRKDIICGRVEIIEQKVYRKGKGI 
ISLKLIDNEPQDGIKVLGNLNVFTSTDRYTQINILYSLIVFSISVIIFIVYVIIELRYLQKKGRFNGLQLM 
NGLLVFAVVGHTFPWNAVAYSIQWIGVFALSKASYSVFNVVFICYLFFMLDSFMKQNGTSSKKVVWITRVL 
LLSIFVVCRLTNTTLHAVCSVQNVLIPKNTLHSTSIFFDVIEGLLYFFLYSWALYHLAMTYNKVTIPIIQK 
QLNYFAACTALFLLVLIFLLFFSGIISEETTFATYFENGSMVVYLISMLCAFLPSLSPVKNEWSIFYNEMD 
DDQPLYDEED 
No 
XP_656583.1 
EDI_050770 
MRNQLIVDTMNRWHFIILTVITILISLAVAGVSIYYHRVVLTTEITPLVVDVSSYSNGTYALMQSLDVQKY 
DKWLEVYLKLEPKNEINEEISFYAETQLHIVKDFHDNVNSFNRTYTTRCFIDKCDDIIFVTDDAVQEAKYI 
ILVAIKDIENKFNSTGLTISLRVSKAFKSHTIFSLSLTIILVFISTITFIILFVIAIKKKEFNIYVNFNLL 
LSFGMILFNDPFVALGFYANYISIEYVDNVLMELYMFILFVWIFFHVDHLKLLAIEEPYPILQWILRSCVL 
IAYFFCFILYFFMNILHHSSSITGSPNPIMDDVKAIRDLLQVVLVFWILMSEFFSFTQVMNPINRKRLFFL 
TPSTLLVAVACVIQLFFQNNSHNNIPIPVCMVKLMNTYFVIVMCFCFYQIKNDLATISLLHTTETNQTILY 
DEYDMFDSEDDKPIL 
No 
XP_001913666.1 
EDI_135050 
MPNGVIIDELGSIWKITLCVVWIICLIIGIFFSFGQILEIGIISNSTTFNVGSSFNGDDTVAFVSFVGNEKKIEGIVDSFNGM
NIVNKIKEDKTDEIENELSSIGLKSSLISLEEDETSSSLSEGDTYYFFDVELLIKTYNQFQATTCKPYVKTDLNHQSVDKITI
SGNATFWWLDHPELNSFDNINKPVKFETQCSFTGGECNRFSFIYLRNVFNSSYTFIFFFKVGFYNTLVMDSKRGIPGYSLFKI
SFVTFLVILSVIATILYSILYFFMKLYKNDEDHFYINSFIMIILLNFYNNPFNILRFFFNADWISCIDTCIYTIYQIVLISFI
FLHIDHSRNQALGKKNSVLIWILRATGLLAYFVFFLLYFILYYLPSNKSPFSVVDDTMSIGLMFGALSTFICFLLYGWTLIYM
LFTYSEIRSPLYKNRIFWFSIFTSVVLIVTLLHLIFGQDMNYLPPISMICRQLLCNLYVYTLTFIFFPKEISNDDEYGITAYT
QF 
No 
XP_650991.1 
EDI_179320 
MNYNNTATTNKEPKLLVSKLSKCGFLLIFAMFVVIVTFCISISMTIPNPWFSKTLSTWDCDEKVSNFDKKICHGIDLNEQKTK
LTVAFGPFTVLNQETRISLIPQKRFGREGISAKGITEISYKLYGSALPIDKNSKVDTNSLELLEEKTITRKVKCPASRGLDCK
AIPLASQIYLTHPNYLLEFTFTPTDISLGDIIVENSYISTSYSVFEMFWRMAFILFSSFCCMLYLSSIRGIPISQWCHEQKWT
FILNIVLILFNNPFFFYEYIVDSVTFLLFNTGIETFFICFLMFYVLSMFEALRKPLNIRKSFRFILPRALLLLTLFMLVFTEL
MYNRTTPNYSITLKGIDDPANVVLSILILGIIVIYIFWLVFGIIRTYSESRKLGPVSLRLKYYGGFTICVIILYLCLLIAANF
MGYHNNASITLTTLAYVNLYVMTLTILYLPVEMNNVPGNRVNLQNNVIHLDEEIKSGDDDLIVVDDEKGNDLIVIDE 
No 
XP_648234.1 
EDI_110620 
MNNSGVLNTNKEQRLLLTTISKIGFFLLFIVFAVLVVIALFVSLNAPKPWSTNEISSWKCAGDDAQFNQNC 
GGVNLLDKSKKITLQLGAYEIFNQESRLEYYFNKKSSKKDIAFDGFVKFRYTLYGTNVLNQPNQKVEVSSL 
KLIEEKTIESKVHCPARSTKCDIGYISSELYLDYPIYIIEISIINENVKDIVSDLIFKASFVSTFYTIFEL 
FWRLIFILFSCLCTCIYLWANRSIPQEKWSHEQKWTVVLLTFLIWENNPLYPYEFLMDNAFYLFVNSVIDT 
IFICFLMFYVLIMFDALRKPIRQRTSIRFYLPRGLLCGLLFSLILASFMYNKTRKIYSPTMTGSHDVFNVI 
ISLGIMGLLIIYLFWLIFSIIRSFSEVRKLGSAGYRVQVYGIFTIFILLFYVSLLLSVFFMGYRNNAAVSL 
TTIAFVNFYCMVLTILYLPSNVVDQKEERAKIVKLDDDEALELKVEDYDNEESHGDEVVIADDEN 
Yes 
(EhGPCR
-1) 
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Figure 5.1.  E. coli K12 lysate stimulation of histidine prototrophism in histidine auxotrophic 
yeast expressing EhGPCR-1.   Yeast growth was measured in histidine-deficient in the presence 
of E. coli K12 lysates.   Growth was also determined in the presence of these lysates plus intact 
anti-LPS antibodies or anti-LPS antibodies digested with proteinase K.   EhGPCR-1 activation was 
also determined in the presence of a rough strain of E. coli K12.  Receptor activation is 
expressed as percent growth over mock-transfected yeast.   Data are expressed as mean + sem.  
For bars with bacteria only, n=6; n=3 for antibody experiments n=3. *p<0.05 versus vehicle. 
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Figure 5.2.  Activation of EhGPCR-1 by bacterial LPS is concentration dependent with an EC50 of 
15 nM, based on an estimated molecular weight of 2,000 gm/mole for LPS.  The open triangle 
represents the response of mock-transfected yeast to the highest concentration of LPS used.  
Each data point represents the mean + sem for three independent experiments.  *p<0.05 
versus mock-transfected. 
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Figure 5.3.  E. histolytica preferentially engulfs E. coli expressing LPS.  Each bar represents the 
mean percentage+ sem of trophozoites that contained bacteria after 25 min. of co-incubation 
(10,000 trophozoites counted per run; each bar represents 3 independent experiments with 3 
replicates of each condition). *p<0.05 versus rough E. coli. 
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Figure 5.4. Suramin inhibits bacterial engulfment by E. histolytica.  Circles represents the mean 
percentage + sem of trophozoites that contained bacteria after 1 hr. of co-incubation (Each dot 
represents 3 independent experiments repeated in triplicate). *p<0.05 versus suramin-free 
control. 
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CHAPTER 6.  CONCLUSIONS 
 
 
FACILITATION OF SALMONELLA DT104 BY PROTOZOA 
 
 Many protozoa engulf bacteria as a source of nutrition and bacterial mechanisms 
related to evasion of protozoan-induced death also enable bacterial pathogenesis in 
vertebrates.  Past studies indicate that bovine rumen protozoa facilitate Salmonella DT104, an 
intracellular pathogen.  First, DT104 is able to survive within the protozoan during transport 
through the rumen.  Second, DT104 is capable of conjugal plasmid transfer while living 
intracellularly.  Third, engulfment of DT104 by rumen protozoa induces a hyperinvasive 
phenotype that is measurable in vitro and leads to increased clinical severity of disease in a calf 
model.   
Prior to the studies presented in this dissertation, it was unknown if other protozoa are 
capable of serving as a venue for DT104 plasmid transfer or inducing DT104 hypervirulence.  
First, in vitro assays were used to evaluate rumen protozoa from sheep, goats, and African 
ruminants.  These assays demonstrated that conjugal plasmid transfer was achieved in all of 
these protozoa.  Assessment of DT104 cell invasion following protozoan engulfment revealed 
that ovine protozoa increased invasion approximately 3 fold while the other types of protozoa 
did not induce a hyperinvasive phenotype.  In vivo studies confirmed these observations; sheep 
and calves infected with DT104 had a more rapid onset of pyrexia and clinical signs.  Altogether, 
these studies provide evidence that conjugal plasmid transfer is a more common phenomenon 
while induction of the DT104 hyperinvasive phenotype occurs only in certain bovine and ovine 
rumen protozoa.  In subsequent studies, Tetrahymena was used as a model protozoan to study 
91 
 
engulfment of DT104.  In vitro cell invasion assays indicated that engulfment of DT104 by 
Tetrahymena induced the hyperinvasive phenotype and this was confirmed in a in vivo (calf) 
model of disease.  
 
PROTOZOAN GPCRS  
 
G protein-coupled receptors are one of the most important group of transmembrane-
signaling receptors.  The investigation of GPCRs from protozoa is only in its infancy and to this 
point has been relegated to studies in model organisms.  No studies have utilized a 
heterologous expression assay for deorphanization of putative protozoan GPCRs.  A goal of this 
dissertation was to identify GPCRs from protozoa with the hypothesis that GPCRs could bind 
bacterial cells and initiate bacterial engulfment. 
Initial studies entailed constructing a cDNA library from bovine rumen protozoa.  
Homologues of genes cloned from this library were identified in Tetrahymena and expression of 
these genes were targeted using an RNAi approach to assess their role in bacterial engulfment.  
Serendipitously, these RNAi studies revealed that knock-down of a cyclic nucleotide binding 
protein severely hampered Tetrahymena engulfment of DT104 and the ability of DT104 to 
induce the hyperinvasive phenotype.  Additional studies conducted utilizing RNAi implicated a 
putative Tetrahymena GPCR in bacterial engulfment. 
A yeast heterologous expression system was utilized for the deorphanization of 
protozoan GPCRs.  In this system, the Tetrahymena GPCR was agonized by Tetrahymena cell 
lysates, suggesting that this receptor detects intercellular signaling molecules.  In the context of 
bacterial engulfment, Tetrahymena GPCRs are probably most relevant in terms of chemotaxis 
since these organisms sweep food items indiscriminately into an oral feeding apparatus.  In 
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contrast, amoebae such as Entamoeba histolytica may rely on receptor based interactions that 
bind bacterial epitopes and lead to engulfment of the bacteria.  EhGPCR-1, a previously 
described GPCR from E. histolytica, was activated by bacterial lipopolysaccharide in the yeast 
expression assay.  Subsequent experiments demonstrated that E. histolytica trophozoites 
engulf bacteria selectively based on the presence of lipopolysaccharide and this feeding could 
be inhibited by the G protein inhibitor suramin. 
The work presented herein revealed the physiologic relevance to GPCR signaling in two 
protozoan organisms, Tetrahymena and E. histolytica.  In addition, a novel yeast heterologous 
expression assay was used to deorphanize GPCRs from these organisms.  These studies 
reinforce the need for further investigation of GPCRs from protozoa especially given the 
significance of these receptors as drug targets. 
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APPENDIX A.  EFFECTS OF SUBTHERAPEUTIC CONCENTRATIONS OF ANTIMICROBIALS ON GENE 
ACQUISITION EVENTS IN YERSINIA, PROTEUS, SHIGELLA, AND SALMONELLA RECIPIENT ORGANISMS IN 
ISOLATED LIGATED INTESTINAL LOOPS OF SWINE 
 Modification of a paper published in the American Journal of Veterinary Research 
  
Matt T. Brewer, Nalee Xiong, Kristi L. Anderson, and Steve A. Carlson 
 
ABSTRACT 
To assess antimicrobial resistance and transfer of virulence genes facilitated by 
subtherapeutic concentrations of antibiotics, we evaluated the conjugation frequency of 
antimicrobial resistance genes in 4 recipient pathogenic bacteria (Salmonella enterica serotype 
Typhimurium, Yersinia enterocolitica, Shigella flexneri, or Proteus mirabilis) in the presence of 
subinhibitory concentrations of 16 antimicrobials in isolated ligated intestinal loops in swine. 
Anesthetized pigs were experimentally inoculated with donor and recipient bacteria. After 
coincubations, intestinal contents were removed and assessed for pathogens that acquired new 
antimicrobial resistance or virulence genes following exposure to the subtherapeutic 
concentrations of antimicrobials. Three antimicrobials (apramycin, lincomycin, and neomycin) 
enhanced transfer of an antimicrobial resistance plasmid from commensal E. coli organisms 
toYersinia and Proteus organisms, whereas seven antimicrobials (florfenicol, hygromycin, 
penicillin G, roxarsone, sulfamethazine, tetracycline, and tylosin) exacerbated transfer of an 
integron (Salmonella genomic island 1) from Salmonella organisms to Yersinia organisms. 
Sulfamethazine induced the transfer of Salmonella pathogenicity island 1 from pathogenic to 
nonpathogenic Salmonella organisms. Six antimicrobials (bacitracin, carbadox, erythromycin, 
sulfathiazole, tiamulin, and virginiamycin) did not mediate any transfer events. Sulfamethazine 
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was the only antimicrobial implicated in two types of transfer events. Use of subtherapeutic 
antimicrobials in animal feed may be associated with unwanted collateral effects.   
 
INTRODUCTION 
Subtherapeutic concentrations of antimicrobials have been used for decades as growth 
promotants and prophylactic agents. This practice has been scrutinized as a contributor to the 
dissemination of antimicrobial resistance. Specifically, subtherapeutic concentrations of 
chlortetracycline have been associated with an increase in resistance to multiple antimicrobials for 
swine intestinal microbes.1 Another study2 revealed that subtherapeutic concentrations of 
antimicrobials can lead to the propagation of antimicrobial-resistant Enterococcus organisms in swine. A 
recent study
3
 indicated that intestinal bacteriophages are activated by subtherapeutic concentrations of 
antimicrobials, and this activation can lead to transfer of antimicrobial resistance genes. However, these 
studies have not addressed specific gene transfer events that precipitate resistance and virulence. Thus, 
little is known about the effects of these antimicrobials on specific gene transfer events that promote 
the dissemination of antimicrobial resistance and virulence genes in enteric pathogens.   
The objective of the study reported here was to identify antimicrobials that, at subtherapeutic 
concentrations, augment the transfer of certain antimicrobial resistance and virulence genes. The main 
goals involved assessing three types of transfer events (plasmid transfer, integron transfer, and 
horizontal transfer of a pathogenicity island) mediated by subtherapeutic concentrations of 
antimicrobials in vivo. Specifically, the study was conducted to determine the relative rates of 
antimicrobial-mediated transfer events involving three representative antimicrobial resistance plasmids, 
one model integron, and one pathogenicity island in the presence of antimicrobials that are or were 
approved for use at subtherapeutic concentrations as feed additives for swine. 
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MATERIALS AND METHODS 
Animals—Twenty juvenile swine were used to assess in vivo transfer events. Pigs were of mixed breeds 
and both sexes and weighed between 5 and 10 kg. Animal experiments were approved by the Iowa 
State University Institutional Animal Care and Use Committee.  
Pigs were anesthetized with pentobarbital
a
 (40 mg/kg, intraperitoneal). Isolated ligated loops of 
intestine (9 loops/pig; each ligated loop was 10 cm in length) were created
4
 with 2-0 silk sutures.
b
 At the 
end of the experiments, anesthetized pigs were euthanized by intracardiac administration of an 
overdose of pentobarbital (100 mg/kg).  
Plasmid transfer—To determine plasmid transfer from donor bacteria to recipient pathogenic bacteria, 
each loop was injected with approximately 10
9
 to 10
11 
CFUs of donor bacteria and 10
9
 CFUs of recipient 
bacteria in 1 mL of saline (0.9% NaCl) solution that contained one of 16 feed additive antimicrobials
c
 
(apramycin, bacitracin, carbadox, erythromycin, florfenicol, hygromycin, lincomycin, neomycin, penicillin 
G, roxarsone, sulfamethazine, sulfathiazole, tetracycline, tiamulin, tylosin, and virginiamycin); 
antimicrobial-free saline solution was used as a negative control treatment. The concentration of each 
antimicrobial was 1 µg/mL. This concentration was chosen because it was less than the established 
breakpoints for all of the antimicrobial-bacteria combinations
5
 and preliminary experiments conducted 
by our laboratory group on the minimum inhibitory concentration of these antimicrobials revealed that 
this was the lowest common concentration that permitted growth of all donor and recipient bacteria in 
each of the 16 antimicrobials (data not shown).  
Plasmid transfer from a donor commensal intestinal Escherichia coli
6
 (antimicrobial susceptible 
and lacking virulence genes) to each of four recipient pathogenic bacteria (Salmonella enterica serotype 
Typhimurium strain SL1344,
7
 Yersinia enterocolitica,
d
 Shigella flexneri,
e
 or Proteus mirabilis
f
) was 
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measured. All of the recipient bacteria were susceptible to most antimicrobials (except tetracycline and 
streptomycin), as determined by use of microdilution broth assays performed in accordance with 
standards established by the Clinical and Laboratory Standards Institute.
5
 The E. coli donor strain was 
experimentally transformed with one of three conjugative plasmids encoding an ESBL,
8
 amikacin 
resistance (aacC4),
9
 or fluoroquinolone resistance (via the qnr gene).
10
  
Bacteria were allowed to incubate in the isolated ligated intestinal loops for 1 hour, after which 
loops were excised. Total volume of intestinal content in each isolated loop was 1.1 to 1.2 mL; 
approximately 10% of the total content of each loop was removed for plating on media selective for 
each of the four pathogens (XLD agar
g
 for Salmonella and Shigella organisms, Yersinia selective agar 
base
h
 for Yersinia organisms, and phenylalanine agar
g
 for Proteus organisms) and that contained one of 
three antimicrobials (ceftiofur
i
 at 32 µg/mL for the ESBL plasmid, amikacinc at 64 µg/mL, or enrofloxacinj 
at 8 µg/mL) at their respective breakpoint concentrations.5 Each loop was cultured in triplicate (three 
agar plates/loop). Control experiments revealed that the donor E. coli did not grow on the selective 
media, except for the XLD agar; however, the E. coli colonies that grew on XLD agar were biochemically 
distinct from the Salmonella and Shigella colonies. 
Plates were incubated at 37oC for 16 hours. Bacteria then were enumerated and the number of 
translocants/10
9
 recipients was calculated by multiplying the number of recovered colonies by 10 to 
account for the fact that only 10% of the intestinal contents were plated. The log10 of the quotient was 
derived and used for final data analysis and statistical evaluation. 
Transfer of the ESBL plasmid was assessed with a PCR assay with primers (5′-
ATGATGAAAAAATCGTTATGCT-3′ and 5′-TTATTGCAGCTTTTCAAGAAT-3′) specific to the blaCMY-2 gene 
present on the ESBL plasmid.8 Each transfer event was determined for 100 representative colonies.   
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SGI1 transfer—The possibility that subinhibitory concentrations of antimicrobials can modulate the 
transfer of SGI1 from Salmonella organisms to Yersinia recipients, Shigella recipients, or Proteus 
recipients was evaluated. The SGI1 is a multiresistance integron that encodes resistance to five 
antimicrobials in Salmonella organisms.
11
 Integrons are mobile genomic elements putatively transferred 
by bacteriophages,
12
 and studies
13–15
 have indicated that Yersinia spp, Shigella spp, and Proteus spp are 
capable of receiving integrons.  
To evaluate SGI1 transfer, approximately 10
9
 CFUs of SGI1-free recipient Yersinia enterocolitica, 
Shigella flexneri, or Proteus mirabilis (all of which were susceptible to most antimicrobials except 
tetracycline and streptomycin), as determined by use of microdilution broth assays performed in 
accordance with standards established by the Clinical and Laboratory Standards Institute
5
) were each 
co-inoculated with 10
9
 CFUs of SGI1-bearing donor S enterica serotype Typhimurium phagetype DT104 
strain LNWI
4
) into ligated intestinal loops. Co-incubations included one of the 16 aforementioned 
antimicrobials (concentration, 1 µg/mL) and the negative control treatment (saline solution without an 
antimicrobial).  
Bacteria were allowed to incubate in the isolated ligated intestinal loops for 1 hour, after which 
loops were excised. Total volume of the intestinal content in each isolated loop was 1.1 to 1.2 mL; 
approximately 10% of the total content of each loop was removed for plating on media selective for 
each of the 3 pathogens (XLD agar for Salmonella and Shigella organisms, Yersinia selective agar base for 
Yersinia organisms, and phenylalanine agar for Proteus organisms) and that contained one of two 
antimicrobials relevant for SGI1 (ampicillin
c
 at 32 µg/mL and chloramphenicolc at 32 µg/mL) at their 
respective breakpoint concentrations.
5
 Each loop was cultured in triplicate (three agar plates/loop). 
Plates were incubated at 37oC for 16 hours. Bacteria then were enumerated and the number of 
translocants/109 recipients was calculated by multiplying the number of recovered colonies by 10 to 
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account for the fact that only 10% of the intestinal contents were plated. The log10 of the quotient was 
derived and used for final data analysis and statistical evaluation. 
A PCR assay specific to the floR-tetR sequence in SGI1
16
 was used to assess the presence of the 
SGI1 integron in 100 representative recipient bacteria that grew on selective media containing ampicillin 
and chloramphenicol. Additionally, transferrants were assessed for the absence of a Salmonella 
virulence gene segment (sipB/C).
16
 Control experiments revealed that the donor Salmonella organisms 
were not able to grow on the media selective for Yersinia spp and Proteus spp, whereas Salmonella 
organisms were distinguishable from Shigella organisms on XLD agar.  
SPI1 transfer—Transfer of SPI1 from pathogenic to nonpathogenic Salmonella organisms was evaluated. 
The SPI1 is a major determinant of virulence in Salmonella organisms, and avirulent Salmonella 
organisms lack SPI1.
17
 The genomic structure of SPI1 suggests that this island is transferrable.
18
 In vivo 
coincubations with the 16 antimicrobials and the negative control treatment (saline solution without an 
antimicrobial) were performed as described previously for the plasmid and integron transfer 
experiments. The SPI1-bearing S enterica serotype Typhimurium (antimicrobial-susceptible strain 
SL1344
7
) was incubated with one of four SPI1-free strains (S enterica serotypes Litchfield,
17
 
Senftenberg,
17
 Seminole, or Betiocky), all four of which were transformed with a nonconjugative plasmid 
encoding green fluorescent protein.
19
 For this experiment, 10
11
 CFUs of donor bacteria and 10
11
 CFUs of 
recipient bacteria were used for the incubations.  
Bacteria were allowed to incubate in the ligated loops for 1 hour.  Total volume of each loop was 
1.1 to 1.2 mL; approximately 10% of the total content of each loop was removed and used in a large-
volume tissue culture invasion assay
20
 in which recovered bacteria were plated on XLD agar that 
contained 50 µg of zeocink/mL (zeocin is the selective marker for the fluorescence plasmid19). Each loop 
was cultured in triplicate (three agar plates/loop). Fluorescent colonies that were invasive (i.e., 
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recovered from inside tissue culture cells) were individually expanded in fresh nutrient broth and then 
subjected to a second invasion assay. Amount of invasion was compared with that of strain SL1344.
7
 
Serotype analysis was conducted at another laboratory,
l
 and a PCR assay that detected the sipB-sipC 
sequence in SPI1
16
 was performed on each clone for which invasion was indistinguishable from that of 
strain SL1344 (approximately 1% invasion).  
Statistical analysis—Statistical differences were assessed via an ANOVA.
m
 There were 51 combinations 
of antimicrobials and transfer events ([16 antimicrobials plus one antimicrobial-free treatment] times 
three transfer events), each assessed in three separate ligated loops (153 total loops) and three agar 
plates/loop (459 total loops). Frequency data for all transfer events were analyzed en masse to allow for 
inter-antimicrobial and intra-event comparisons and intra-antimicrobial and inter-event comparisons 
[i.e., comparisons were made among the antimicrobials within the 3 transfer events (plasmid, SGI1, and 
SPI1) and among the three transfer events within a specific antimicrobial]. The Scheffe F test was chosen 
as the ad hoc test because our research group has empirically found it to be the most conservative for 
detecting differences, in contrast to the Bonferroni test. Values of P < 0.05 were considered significant.   
  
RESULTS 
Plasmid transfer—In vivo transfer events of three clinically relevant antimicrobial resistance plasmids 
were assessed by use of ligated intestinal loops of swine. Loops were co-inoculated with donor 
commensal E coli bearing one of three antimicrobial resistance plasmids, one of four recipient 
pathogenic Enterobacteriaceae, and an antimicrobial (1µg/mL) approved as a feed additive in swine. 
Commensal E. coli and recipient Enterobacteriaceae were chosen because these microbes are highly 
representative of enteric bacteria that transfer genetic information. Three antimicrobials mediated a 
significant increase in the frequency of a specific plasmid transfer event in vivo (Figure 1). An increased 
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frequency of transfer of the ESBL plasmid from E coli to Yersinia recipients and from E. coli to Proteus 
recipients was evident in the presence of apramycin, lincomycin, or neomycin.  None of the 
antimicrobials caused significant changes in the frequencies of ESBL plasmid transfer from E. coli to 
Salmonella recipients and from E. coli to Shigella recipients. Additionally, none of the antimicrobials 
caused significant changes in transfer of amikacin resistance plasmids or fluoroquinolone resistance 
plasmids.   
The PCR assay of 100 representative ceftiofur-resistant colonies from each of the 
aforementioned transfer events revealed that 96% to 97% of the putative transconjugates contained 
blaCMY-2. Colonies that lacked this sequence were numerically discounted as transconjugates in the final 
calculations (Figure 1).  
SGI1 transfer—In vivo transfer events of an integron were assessed via ligated intestinal loops co-
inoculated with donor Salmonella organisms bearing SGI1,
11
 one of four recipient pathogenic 
Enterobacteriaceae, and an antimicrobial (1 µg/mL) approved as a feed additive in swine. Seven 
antimicrobials mediated a significant increase in the frequency of in vivo transfer of a specific integron 
(Figure 2). An increased frequency of transfer of the SGI1 integron from Salmonella organisms to 
Yersinia organisms was evident in the presence of florfenicol, hygromycin, penicillin G, roxarsone, 
sulfamethazine, tetracycline, and tylosin. None of the antimicrobials caused significant changes in the 
frequencies of SGI1 transfer events from Salmonella organisms to either of the other two pathogens 
examined. The PCR assay of 100 representative colonies from each of the 16 aforementioned transfer 
events revealed that 98% to 99% of the putative SGI1 recipients contained the floR-tetR sequence 
indicative of SGI1.
16
 Colonies that lacked this sequence were numerically discounted as translocants in 
the final calculations. 
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SPI1 transfer—In vivo transfer events of a pathogenicity island were assessed via ligated intestinal loops 
co-inoculated with donor Salmonella organisms, one of four recipient nonpathogenic Salmonella 
organisms that lacked SPI1, and an antimicrobial (1 µg/mL) approved as a feed additive in swine. 
Sulfamethazine mediated the horizontal transfer of SPI1 in vivo (Figure 3).  Three of four SPI1-free 
Salmonella serovars (Betiocky, Seminole, and Litchfield) had transfer events in the presence of 
sulfamethazine. Transfer of SPI1 was detected in the absence of an antimicrobial for one clone of 
Salmonella serovar Litchfield. Salmonella enterica serovar Senftenberg did not acquire SPI1 in this 
experiment. Results of the PCR assays confirmed the presence of the sipB-sipC genomic segment in all 
clones that had invasion indistinguishable from that of strain SL1344. 
 
DISCUSSION 
The use of subtherapeutic concentrations of antimicrobials in livestock feed is a controversial practice 
that is being scrutinized. Of concern are the unknown collateral effects on bacterial gene transcription, 
plasmid transconjugation from commensals to pathogens, and viral-mediated transduction of genes 
from commensals to pathogens and from one pathogen to another.  Specifically, these collateral effects 
can activate molecular processes culminating in gene transfer events that yield pathogens with multiple 
antimicrobial resistance or pathogens with new virulence capabilities. 
 
The experiments in the present study involved the use of low concentrations (1 µg/mL) of 
antimicrobials to mimic field conditions without directly harming the donor or recipient bacteria.  
Although this concentration may be lower than concentrations in the intestinal tract of swine fed feed 
that contains antimicrobials, this concentration was considered relevant for swine in which the 
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antimicrobial is removed from the diet prior to slaughter. 
The present study revealed that there were transfer events in the absence of an antimicrobial 
and that certain antimicrobials mediated gene transfer events at a higher frequency than did other 
antimicrobials (Table 1). Sulfamethazine mediated two separate transfer events (SGI1 transfer and SPI1 
transfer), whereas a related drug, sulfathiazole, did not mediate any transfer events.  Bacitracin, 
carbadox, erythromycin, tiamulin, and virginiamycin were also not implicated in transfer events. 
Transfer events were confirmed with a PCR assay, although a few (1% to 4%) transconjugates and 
translocants did not harbor the transferrable element, which suggested that efflux systems may have 
been activated in these few clones. 
Three classes of antimicrobials were implicated in transfer to the ESBL plasmid. Lincomycin is a 
lincosamide, apramycin is an aminocyclitol, and neomycin is an aminoglycoside (although the latter 2 
are sometimes grouped in the same class). Lincomycin is an inhibitor of the 50S ribosome in bacteria, 
yet 3 other 50S inhibitors (erythromycin, tiamulin, and virginiamycin) did not mediate transfer events. 
Apramycin and neomycin are inhibitors of the 30S ribosome, but another 30S inhibitor, tetracycline, did 
not exacerbate transfer of the ESBL plasmid. It is possible that apramycin, lincomycin, and neomycin can 
selectively alter protein synthesis that impacts sex pheromones and conjugation. 
 
Seven antimicrobials (florfenicol, hygromycin, penicillin G, roxarsone, sulfamethazine, tetracycline, and 
tylosin) from 7 antimicrobial classes were implicated in transfer of SGI1.  Tylosin and florfenicol are 50S 
inhibitors, but that is the extent of the similarities among these seven antimicrobials. Because 
movement of SGI1 may be a phage-mediated event,12 it is possible that those seven antimicrobials 
activated phage recrudescense in SGI1-bearing Salmonella organisms, similar to that recently reported 
for sulfamethazine, chlortetracycline, and penicillin.
3
 It is also possible that naked SGI1 DNA was 
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transferred from Salmonella organisms to Yersinia organisms, although to our knowledge this process 
has not been described in the literature. 
Analysis of results of the present study indicated that certain antimicrobials at subtherapeutic 
concentrations are more likely to mediate unwanted gene transfer into pathogenic bacteria in ligated 
intestinal loops in swine. Sulfamethazine mediated 2 different types of transfer, whereas apramycin, 
lincomycin, and neomycin exerted the greatest quantitative effect on a single transfer event into two 
genera of Enterobacteriaceae. Bacitracin, carbadox, erythromycin, sulfathiazole, tiamulin, and 
virginiamycin did not significantly influence any of the three transfer events evaluated. No antimicrobial 
class–specific patterns were observed in the three transfer events. Transfer of the ESBL plasmid was 
detected at the highest frequency. Protein synthesis irregularities may underlie transfer of the ESBL 
plasmid, and activation of bacteriophages may be involved in SGI1 transfer or SPI1 transfer (or both). 
Regardless of the mechanisms involved, subtherapeutic concentrations of antimicrobials have potential 
ecologic impacts that involve the dissemination of antimicrobial resistance and virulence genes.  
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Figure 1—Plasmid transfer from commensal Escherichia coli to Yersinia organisms and Proteus 
organisms after co-incubation with subtherapeutic concentrations (1 ug/mL) of lincomycin (white bars), 
apramycin (gray bars), or neomycin (striped bars) or saline (0.9% NaCl) solution that did not contain an 
antimicrobial (negative control treatment [black bars]) for 1 hour in isolated ligated intestinal loops in 
swine. Results represent the mean ± sem for three experiments that each was performed in triplicate. 
Notice that there was enhancement of transfer of the ESBL plasmid
8
 in the presence of subtherapeutic 
concentrations of antimicrobials in Yersinia recipients and Proteus recipients. *Within a bacterium, value 
differs significantly (P < 0.05) from the value for the co-incubation with the negative control treatment.   
 
 
 
 
 
 
 
107 
 
 
Figure 2—Transfer of SGI1 from Salmonella enterica serotype Typhimurium phagetype DT104 to Yersinia 
enterocolitica after co-incubation with subtherapeutic concentrations (1 ug/mL) of 16 antimicrobials or 
saline solution that did not contain an antimicrobial (negative control treatment) for 1 hour in isolated 
ligated intestinal loops in swine. Results represent the mean ± sem for three experiments that each was 
performed in triplicate. Notice that transfer of the integron was enhanced in the presence of seven 
antimicrobials. *Values differs significantly (P < 0.05) from the value for coincubation with the negative 
control treatment. SMZ = Sulfamethazine. 
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Figure 3—Transfer of SPI1 from pathogenic Salmonella organisms to nonpathogenic Salmonella 
organisms after co-incubation with subtherapeutic concentrations (1 ug/mL) of sulfamethazine (white 
bars) or saline solution that did not contain an antimicrobial (negative control treatment [black bars]) for 
1 hour in isolated ligated intestinal loops in swine. Fluorescent bacteria were subjected to two invasion 
assays, and colonies that were invasive (i.e., recovered from inside tissue culture cells) were quantitated 
by enumerating the bacteria recovered from tissue culture cell lysates at the end of the second assay. 
Invasion represents the percentage as compared with that of the donor Salmonella organisms. Results 
represent the mean ± sem for three experiments that each was performed in triplicate. Notice that 
transfer of SPI1 was only detected in the presence of sulfamethazine and that one clone of S. enterica 
serotype Litchfield was invasive in the absence of an antimicrobial. The number above each column 
indicates the cumulative number of serovar-specific clones that were invasive across three separate 
experiments.  
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Table 1—Gene transfer events for donor bacteria to recipient bacteria after co-incubation with 
subtherapeutic concentrations (1 ug/mL) of 16 antimicrobials or saline (0.9% NaCl) solution that did not 
contain an antimicrobial (negative control treatment) for 1 hour in isolated ligated intestinal loops in 
swine.  
Antimicrobial ESBL plasmid 
transfer  
SGI1 transfer  SPI1 transfer  Ratio of total 
transfer 
frequencies✝ 
Saline solution   NA NA NA 1.0 
     
Apramycin Yersinia recipients 
and Proteus 
recipients* 
— — 3,471 
Bacitracin — — — 2.3 
Carbadox — — — 0.6 
Erythromycin — — — 0.7 
Florfenicol — Yersinia recipients*  9.8 
Hygromycin — Yersinia recipients*  5.1 
Lincomycin Yersinia recipients 
and Proteus* 
— — 4,596 
Neomycin Yersinia and 
Proteus* 
— — 4,641 
     
Penicillin G — Yersinia recipients*  4.4 
Roxarsone —  Yersinia recipients*  4.7 
Sulfamethazine — Yersinia recipients* 3 recipient 
nonpathogenic 
serovars of 
Salmonella 
enterica*† 
13.6 
Sulfathiazole — — — 1.1 
Tetracycline — Yersinia recipients* — 4.1 
Tiamulin — — — 1.2 
Tylosin — Yersinia recipients* — 10.3 
Virginiamycin — — — 0.9 
Mean transfer frequency in the absence of an antimicrobial was approximately 1.4 X 10–8 
transconjugates/recipient for the ESBL plasmid, 2.6 X 10–9 translocants/recipient for SGI1, and 3 X 10–11 
invasive clones/noninvasive recipient for SPI1; these frequencies were calculated by dividing the total 
number of all recovered recipients by the total number of donor bacteria added to all of the co-incubations 
in the absence of an antimicrobial. For each antimicrobial, the ratio of total transfer frequency  = (total 
number of all bacteria that received the new genetic element when co-incubated with an 
antimicrobial/total number of recipients co-incubated with an antimicrobial)/ (total number of all bacteria 
that received the new genetic element when co-incubated without an antimicrobial/total number of 
recipients co-incubated without an antimicrobial).   
*Transfer frequency was significantly (P < 0.05) greater than the transfer frequency for the antimicrobial-
free (negative control) treatment. †Salmonella enterica serotypes Betiocky, Litchfield, and Seminole. 
NA = Not applicable. — = Transfer frequency was not significantly greater than the transfer frequency 
for the antimicrobial-free (negative control) treatment.   
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APPENDIX B.  AMELIORATION OF SALMONELLOSIS IN PRE-WEANED DAIRY CALVES FED 
SACCHAROMYCES CEREVISIAE FERMENTATION PRODUCTS IN FEED AND MILK REPLACER 
 
Modification of a paper submitted to Veterinary Microbiology 
Matthew T. Brewer, Kristi L. Anderson, Ilkyu Yoon, Mark F. Scott, and Steve A. Carlson 
 
ABSTRACT 
Salmonellosis is an insidious and potentially epidemic problem in pre-weaned dairy calves.  
Managing this disease, or any other diarrheal disease, is a financial burden to producers.  Calf 
mortalities and medicinal treatments are overt costs of salmonellosis, while hidden costs 
include hampered weight gains and persistent intestinal colonization of the pathogen.  In this 
study, we examined the anti-Salmonella effects of Saccharomyces cerevisiae fermentation 
products (SCFP) incorporated into both the milk replacer and the starter grain.  In a blinded 
study, 2 to 8 day-old calves were fed SCFP (n = 20 calves) or an SCFP-free Control (n = 20 calves) 
for two weeks before and three weeks after experimental challenge with Salmonella enterica 
serotype Typhimurium.  Following the challenge, calves were monitored for clinical signs and 
parameters associated with salmonellosis.  Calves were then euthanized and examined for 
rumen development and intestinal Salmonella colonization.  When compared to calves that 
received milk replacer and feed lacking SCFP, calves fed SCFP had fewer bouts of diarrhea and 
fever.  Rumens from these calves were more developed, as measured by the length of papillae, 
which is consistent with the enhanced weight gain observed in this treatment group.  
Additionally, Salmonella intestinal colonization was reduced in SCFP-fed calves and Salmonella 
fecal shedding disappeared at an earlier stage in these calves.  This study revealed that the 
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combination of two proprietary Saccharomyces cerevisiae fermentation products provide 
marked benefit for preventing the negative effects of salmonellosis in pre-weaned dairy calves, 
while also boosting productivity.  The mechanism of action needs to be clarified, but it may be 
related to the observed decrease in colonization by the pathogen and increase in rumen 
development. 
Key words: Salmonella infection, dairy calf, yeast culture  
 
INTRODUCTION 
   Salmonellosis is one of the many diarrheal diseases affecting pre-weaned dairy calves.  
Salmonella organisms are commonly isolated from dairy farms and the fecal-oral transmission 
route can occur from dam to offspring.  Calves can also acquire the organism from fecal-
contaminated fomites or the environment.  Calves manifest the disease as diarrhea, fever, 
anorexia, and dehydration all of which significantly compromise the development and 
maturation of the animal.  Further costs include treatment with electrolytes or antibiotics or 
both, and some calves still perish because of the increasing prevalence of antibiotic resistance 
in Salmonella [1] and hypervirulence associated with multi-resistant strains (Rasmussen et al., 
2004).  Furthermore, calves that survive salmonellosis can be long-term carriers of the 
pathogen [2] and these adult animals can serve as a persistent source for new infections in the 
herd [3].  Environmental persistence also contributes to this problem [3]. 
   Preventing Salmonella infections currently focuses on a vaccine technology [4].  
Unfortunately, this vaccine is only for cattle that are six months or older thus pre-weaned 
calves are dependent upon colostral passive immunization from the vaccinated dam.  Anti-
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Salmonella bacterins have been tried but are frequently unsuccessful because of the 
immunodominance of the Salmonella O-antigen (Barat et al., 2012) and serovar specificity 
(House et al., 2001).   Anti-lipopolysaccharide antiserum and lipopolysaccharide toxoids are 
available but the anti-Salmonella benefits have not been clearly established.  Thus Salmonella 
prophylaxis is not optimal at this time in the pre-weaned calf (Lanzas et al., 2008), although 
vaccinating the dam will reduce the environmental exposure of the calf. 
 It has been shown that soluble components present in Saccharomyces cerevisiae 
fermentation products (SCFP) enhance gut health [5] and promote immune function (Jensen et 
al. 2007).  When supplemented to the starter grain, SCFP improved rumen development, 
starter grain intake, and BW gain of non-challenged calves (Lesmeister et al., 2004).  
Additionally, SCFP was shown to improve the gastrointestinal health of calves in a Salmonella 
endemic herd [6].  Because of these benefits associated with SCFP, we examined its anti-
Salmonella effects when fed to pre-weaned dairy calves experimentally infected with 
Salmonella.  The specific aims of this study were to determine the effects of the combination of 
two proprietary SCFP (Diamond V SmartCare™ and Diamond V Original XPC™) on the growth 
and rumen development, clinical signs of salmonellosis, Salmonella shedding, and intestinal 
colonization of Salmonella in pre-weaned dairy calves experimentally infected with Salmonella. 
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MATERIALS AND METHODS 
Calves and Pre-infection Treatments 
    Animal experiments were approved by the Animal Care and Use Committee at Iowa 
State University.  Forty Holstein or Holstein-cross calves (32 females and eight males) were 
purchased from a local supplier in northwest Iowa.  Calves were fed colostrum for the first two 
days after birth and then fed a standard milk replacer until shipment to Iowa State University at 
two to eight days of age.  Upon arrival at an animal biosafety level-2 building at Iowa State 
University, calves were weighed (28 to 47 kg, with Holstein-Jersey crosses representing the 
lower weights) and randomly assigned (without redistribution) to one of two separate but 
adjacent rooms.  Each room had constant ambient temperatures (about 22
o
C) and humidity 
(about 40%) and was ventilated by negative pressure through HEPA filters.  Calves were housed 
in individual 18 m
2
 pens on Tenderfoot-type flooring without bedding. 
 Two separate experiments were performed each using 20 calves (10 per group) of 
similar ages (2-4 days in one experiment and 6-8 days in the other experiment), and treatment 
groups were alternated in the two different rooms in each experiment in order to avoid a 
“room effect”.  Each room was fed either SCFP or the Control to avoid the potential for 
inappropriate administration of a treatment within a room.  Rooms were alternated between 
the two experiments, i.e., in the first experiment calves in “Room A” received SCFP while calves 
in this same room received the Control in the second experiment. 
Calves were randomly assigned to one of two treatments: Control (no additive in milk 
replacer or starter grain) or diet that contained two proprietary Saccharomyces cerevisiae 
fermentation products delivered separately (SCFP; 1 g/head/d SmartCare™ [0.15% inclusion 
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rate in conventional milk replacer] and 3.5 g/head/d Original XPC™ administered orally via 
gelatin capsule; Diamond V, Cedar Rapids, Iowa).  SmartCare is a water dispersible product that 
can be added directly to milk or milk replacer as a supplement for pre-weaning liquid calf diets 
(starting at d 1).  Original XPC is dry feed product commonly used in pre-weaning calf starter 
diets.  The combination of these products is the basis for Diamond V’s dairy calf program during 
the pre-weaning phase.  A gelatin capsule containing 3.5 g/head/d grain matrix used to produce 
XPC was given to Control calves to equalize the nutrients, although minimal, contributed by 
XPC. 
 All calves were fed a non-medicated milk replacer (20% all-milk protein, 20% fat; Land 
O’Lakes Animal Milk Products, Shoreview, MN) at a volume equivalent rate of approximately 
10% of arrival BW twice per day (i.e., 5% of BW each feeding) for the duration of the trial.  Milk 
replacer was mixed in single batches using warm water and a cordless drill-driven stirrer.  
Specifically, each calf received 6 oz of milk replacer in 1 qt water bid, in which the milk replacer 
was 18.8% w/v of the solution. 
 Calves were fed calf starter (Calf Startena™, 18% crude protein, 0.005% decoquinate, 
Purina Mills, LLC, St. Louis, MO) and water ad libitum, although it was not feasible to measure 
intake of either because of spillage and other uncontrollable factors.  The Iowa State University 
investigators (M.T.B., K.L.A., and S.A.C.) were blinded as to which calves received the Control or 
SCFP treatments.  Specifically, the Diamond V investigators (I.Y. and M.F.S.) notified a third 
party (scientists at the Office of Intellectual Property at Iowa State University) as to the identity 
of the treatment groups prior to the onset of the studies.  Once the studies were completed, 
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the Iowa State University investigators revealed the data to the Office of Intellectual Property 
who then revealed the identity of the treatment groups. 
    In the two-week pre-infection phase, six to seven calves from each group were orally 
treated with one dose of sulfamethazine (356 mg/kg; Sustain™, Bimeda, Oakbrook Terrace, IL) 
for veterinarian diagnosed coccidial infections manifested by blood in the feces.  This treatment 
alleviated the bloody feces within 3 d of treatment.  Treatment with sulfamethazine was 
deemed to not have a negative effect on the outcome of the trial since the Salmonella strain 
used in this study is resistant to sulfonamides and equivalent numbers of calves from each 
experimental group were subjected to sulfamethazine treatment. 
 
Salmonella Infection of Calves 
   Calves were confirmed to be Salmonella-free by fecal culture on arrival and on d 7 and 
12 post-arrival.  Specifically, 1 g of freshly voided feces was diluted in 20 mL of Lennox L broth 
(Invitrogen, Carlsbad, CA).  After settling, an aliquot (100 µL) of this mixture was streaked onto 
and then incubated overnight at 37
o
C on XLD agar (Fisher Scientific, Pittsburgh, PA) selective for 
Salmonella that appear as red colonies with black centers.  All pre-infection fecal samples were 
free of Salmonella.  Sulfamethazine was not used in the XLD agar for pre-infection assessment.  
SL1344 was plated on XLD as a positive control during the experiments. 
    At d 14 post-arrival (d 0 post-infection), calves were orally inoculated with Salmonella 
enterica serotype Typhimurium strain SL1344 [7] at the dose of 2 x 10
6
 CFU/kg BW [8-10].  The 
Salmonella inoculum was prepared and dosed as described previously by the Carlson laboratory 
[8-10].  The inoculum was placed in the gelatin capsule containing the Control or SCFP, which 
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was administered using a small balling gun.  Our empirical studies revealed that the strain 
SL1344 was viable after incubation with either the Original XPC
TM
 or the Control treatment.  
That is, pre-inoculated experiments revealed that SL1344 was 100% viable and recoverable 
after remaining in the Control- or SCFP-containing gelatin capsule for 24 hrs (data not shown). 
 
Assessment of Clinical Parameters in Calves 
    Pyrexia and diarrhea are frequently observed components of salmonellosis in calves 
[11].  On d 0, 1, 2, 3, 4, 5, 6, 7, 10, and 21 post-infection, rectal temperatures were measured 
and diarrhea was assessed on an ordinal scale.  Diarrhea scoring was as follows: 0, no diarrhea; 
1, mild diarrhea; 2, profuse diarrhea; or 3, profuse diarrhea with blood.  This determination was 
performed by one investigator (S.A.C.), who was blinded to the treatment groups, with vast 
experience with experimental salmonellosis.  
 
Assessment of Salmonella Shedding in Calves 
   Fecal shedding of Salmonella is a highly variable and sporadic occurrence in calves 
infected with Salmonella [12].  Nonetheless, this event is of importance for the spread of this 
pathogen [13].  On d 0, 1, 2, 3, 4, 5, 6, 7, 10, and 21 post-infection, 1 g of freshly voided feces 
was briefly vortexed in 20 mL of Lennox L broth (Invitrogen, Carlsbad, CA).  An aliquot of this 
mixture (100 µL) was incubated overnight at 37oC on XLD agar containing the Committee on 
Laboratory Standards Institute-derived [14] breakpoint concentration (512 µg/mL) of 
sulfamethazine (Sigma Aldrich, St. Louis, MO), i.e., a concentration that will enable the growth 
of SL1344 but will inhibit the growth of many other enteric bacteria.  The following day red 
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colonies with black centers were enumerated and CFU/g of feces was calculated based on a 
dilution factor equal to 200. 
 
Assessment of Intestinal Colonization by Salmonella  
    Intestinal colonization by Salmonella contributes to the persistence of the pathogen [3] 
and the fecal shedding that transmits the microbe to other cattle.  On d 21 post-infection, all 
calves were euthanized using xylazine (0.5 mg/kg, intramuscular, Lloyd Laboratories, Walnut, 
CA) and pentobarbital (100 mg/kg, intravenous, Fort Dodge Laboratories, Fort Dodge, IA).  A 2 
cm section (approximately 1 g) of distal ileum was aseptically removed from each calf and cut 
longitudinally.  Each section was placed in 20 mL Lennox L broth (Invitrogen, Carlsbad, CA) and 
briefly vortexed to dislodge the Salmonella.  An aliquot (100 µL) of this mixture was then 
dispersed onto XLD agar containing sulfamethazine (to prevent the growth of other bacteria) 
that were incubated overnight at 37
o
C.  The following day red colonies with black centers were 
enumerated and CFU/g of ileum was calculated based on a dilution factor equal to 200. 
 
Assessment of Rumen Development in Calves 
    Salmonella, and any other enteric pathogen, can have a negative impact upon 
performance in the pre-weaned calf.  It was hypothesized that SCFP may abrogate 
salmonellosis by promoting overall gastrointestinal health and improving rumen development 
in pre-weaned calves.  Therefore, both weight gain and the size of rumen papillae were 
assessed in Salmonella-infected calves fed SCFP.  Following euthanasia, a 4 cm
2
 section of a 
ventrolateral portion of the rumen was removed and placed in 10% buffered-neutral formalin.  
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Rumen tissues were submitted to the Histopathology Laboratory at the College of Veterinary 
Medicine at Iowa State University.  Tissues were prepared using standard hematoxylin and 
eosin staining.  Length and width of rumen papillae were measured using an intra-ocular ruler.  
Measurements were collected from 10 randomly selected papillae present on two different 
sections (i.e., five papillae from each section).  Widths were measured at mid-shaft. 
 
Statistical Analyses 
    For data in which assessments were performed on multiple days (rectal temperatures, 
diarrhea scores, and fecal shedding), statistical comparisons were made using a repeated 
measures analysis of variance with Tukey’s ad hoc test for multiple comparisons (GraphPad 
Prism, Version 6, La Jolla, CA).  For data involving single measurements from each calf 
(intestinal colonization and rumen papillae length), statistical comparisons were performed 
using a student’s t-test (GraphPad).  Significant differences were defined at P ≤ 0.05.  Statistical 
trends were consistent when the two sets of experiments were examined independently (data 
not shown). 
 
RESULTS 
Assessment of Clinical Parameters in Calves 
    Rectal temperatures and diarrhea we monitored in the calves on d 0, 1 through 7, 10, 
and 21 post-infection.  As shown in Figures 1 and 2, pyrexia (rectal temperature > 39.2
o
C) and 
diarrhea were observed less frequently (P < 0.05) in calves fed SCFP.  The largest differences 
between calves supplemented with SCFP and Control calves were observed on d 3 to 5 post-
119 
 
infection for rectal temperatures (38.8 to 39.0
o
C versus 39.5 to 39.7
o
C, respectively), and d 3 
through 7 post-infection for diarrhea scores (0.10 to 0.25 versus 0.61 to 0.86 arbitrary units, 
respectively).  None of the SCFP-fed calves exhibited pyrexia at anytime throughout the study, 
while nearly all Control calves exhibited pyrexia on d 2 through 6 post-infection.  The relative 
incidence of diarrhea was less in SCFP-fed calves on all days except day 0 (Fig. 2b). 
 
Assessment of Salmonella Shedding in the Calves 
    Salmonella fecal shedding was monitored on d 0, 1 through 7, 10, and 21 post-infection.  
As shown in Figure 3a, there was a quantitative difference in fecal shedding between the two 
groups of calves on d 6 post-infection in which shedding was less (P < 0.05) in calves fed SCFP 
(undetectable versus 955 CFU/g of feces).  There also was a qualitative difference in fecal 
shedding of Salmonella on d 3 through 7 post-infection (Fig. 3b). 
 
Assessment of Intestinal Colonization by Salmonella in the Calves  
    Upon euthanasia, ileal sections were excised and subjected to Salmonella culture and 
enumeration that quantifies intestinal colonization of Salmonella.  As shown in Figure 4, fewer 
(P < 0.05) Salmonella were present in the ilea of calves fed SCFP (1,620 versus 9,289 CFU/g of 
ileum).  
Assessment of Rumen Development and Weight Gain in the Calves 
As shown in Figures 5 and 6, rumen papillae length was greater (P < 0.05) in calves fed 
SCFP (236 versus 203 µm) while papillae width was indistinguishable (50 versus 40 µm).  Table 1 
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shows the body weight at different stages of experiment and Figure 7 reveals the superior (P < 
0.05) weight gain in Salmonella-infected calves fed SCFP (23.8 versus 17.2%). 
 
DISCUSSION 
    Salmonella is an insidious problem for the dairy industry.  This problem represents a 
critical animal health issue since cattle of all ages are affected by the pathogen.  Adult cattle will 
exhibit diarrhea and anorexia, both of which compromise the performance of the animal.  In 
the pre-weaned calf, Salmonella can cause diarrhea and malaise that will also hamper 
performance and expose caretakers to the pathogen.  Furthermore, salmonellosis in the pre-
weaned calf can lead to persistent infection and the carrier state.  These animals become an 
asymptomatic source of Salmonella for the herd, while some animals may perish because of the 
infection. 
    Identifying Salmonella mitigation strategies is of critical significance yet the progress is 
very slow.  In this study, the anti-Salmonella effects of SCFP were examined and three critical 
indicators of salmonellosis (pyrexia, diarrhea, and intestinal colonization) were significantly 
reduced by SCFP.  The absence of pyrexia and the diminished diarrhea in the calves fed SCFP 
are consistent with the reduced intestinal colonization by Salmonella.  Both pyrexia and 
diarrhea are dependent upon pathogen burden and it appears that Salmonella may be less 
efficient at attaching to the intestinal tract in the presence of SCFP.  This diminished intestinal 
colonization was manifested by a cessation of Salmonella shedding in calves fed SCFP at 4 d 
prior to the last day of fecal shedding in calves fed the Control.  In Control-fed calves, a higher 
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number of Salmonella colonized the intestinal tract thus extending the overall shedding period, 
which ultimately increased the risk of disease transmission.  
 Our results are consistent with a previous study [6] in which feeding SCFP led to an 
improvement of gastrointestinal health in pre-weaned dairy calves naturally exposed to 
Salmonella.  Although the mechanism of action is yet to be clarified, the effect of SCFP on 
intestinal colonization (Ibukic et al., 2012) and growth (Broomhead, et al., 2012; Nsereko et al., 
2013) of Salmonella has also been reported in poultry. 
    Other significant findings in this study are the improved weight gain and rumen papillae 
maturation in calves fed SCFP, which is consistent with a non-infectious study whereby 
supplemental SCFP improved pre-weaning calf growth, feed intake, and corresponding rumen 
development parameters [15].  Although it is unclear how these parameters were improved by 
feeding the Saccharomyces cerevisiae fermentation products, these findings suggest an 
economic benefit for inclusion in milk replacer and starter grain as demonstrated previously 
(Magalhães et al., 2008).  It is likely that these benefits extend to calves in herds even in which 
Salmonella is not endemic.  Furthermore, it is possible that these benefits extend to protection 
from related enteric pathogens such as E. coli since previously reported studies suggested SCFP 
could inhibit the growth of E. coli (Jenson et al., 2008b).  Future studies will assess this 
possibility. 
 
CONCLUSIONS 
    In summary, Salmonella-infected dairy calves were significantly less likely to exhibit 
clinical signs associated with salmonellosis when fed SCFP.  Specifically, these calves were less 
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likely to exhibit pyrexia and diarrhea, possibly as a direct result of diminished intestinal 
colonization by Salmonella.  Ultimately, these protective effects augmented growth and 
improved rumen development in the calves infected with a serious enteric pathogen. 
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Table 1.  Effect of Saccharomyces cerevisiae fermentation products (SCFP) on body weight of calves 
before and after Salmonella challenge
1
.   
 
 
Treatment2 
Body Weights (mean + SEM) (kg)  % Growth (mean + SEM) 
d 0 (start) d 14 (at 
challenge) 
d 35 
(end) 
 % growth 
from d 0 
to d 14 
% growth 
from d 14 
to d 35 
% growth 
from d 0 to 
d 35 
Control 42.8 + 0.7 45.1 + 0.7 50 + 0.8  5.3 + 0.2 10.9 + 0.2 16.7 + 0.5 
SCFP 40.3 + 1 42.5 + 1.1 50 + 1.4  5.5 + 0.5 17.4 + 0.9* 23.8 + 0.8* 
1Salmonella enterica serotype Typhimurium strain SL1344 at the dose of 2 x 106 CFU/kg BW.   
2Control – no additive in milk replacer or starter grain; SCFP -  diet that contained two proprietary 
SCFP products (1 g/head/d SmartCare™ [0.15% inclusion rate in conventional milk replacer] and 3.5 
g/head/d Original XPC™ administered orally via gelatin capsule; Diamond V, Cedar Rapids, Iowa) 
*P <0.05 versus Control when comparing growth rates. 
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Figure 1.  Time course of rectal temperatures in Salmonella-infected calves fed SCFP or the 
Control.  Treatments include Control (no additive in milk replacer or starter grain) or SCFP (diet 
that contained two proprietary Saccharomyces cerevisiae fermentation products (1 g/hd/d 
SmartCare™ [0.15% inclusion rate in conventional milk replacer] and 3.5 g/hd/d Original XPC™ 
administered orally via gelatin capsule; Diamond V, Cedar Rapids, Iowa).  Data represent the 
mean + SEM for single daily measurements on 20 calves in each group.  The dashed line 
represents the upper limit of the normal rectal temperature for a calf.  *P <0.05 versus Control. 
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Figure 2a.  Time course of diarrhea scores in Salmonella-infected calves fed SCFP or the Control.  
Treatments include Control (no additive in milk replacer or starter grain) or SCFP (diet that 
contained two proprietary Saccharomyces cerevisiae fermentation products (1 g/hd/d 
SmartCare™ [0.15% inclusion rate in conventional milk replacer] and 3.5 g/hd/d Original XPC™ 
administered orally via gelatin capsule; Diamond V, Cedar Rapids, Iowa).  Diarrhea scoring was 
as follows: 0, no diarrhea; 1, mild to moderate diarrhea; 2, profuse diarrhea; or 3, profuse 
diarrhea with blood.  Data represent the mean + SEM for single daily measurements on 20 
calves in each group. *P <0.05 versus the Control. 
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Figure 2b.  Time course of diarrhea incidences in Salmonella-infected calves fed SCFP or the 
Control.  Treatments include Control (no additive in milk replacer or starter grain) or SCFP (diet 
that contained two proprietary Saccharomyces cerevisiae fermentation products (1 g/hd/d 
SmartCare™ [0.15% inclusion rate in conventional milk replacer] and 3.5 g/hd/d Original XPC™ 
administered orally via gelatin capsule; Diamond V, Cedar Rapids, Iowa).  Percentages are based 
on the number of calves exhibiting any type of diarrhea on a given day, with n=20 per group on 
all days. 
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Figure 3a.  Time course of Salmonella fecal shedding in Salmonella-infected calves fed SCFP or 
the Control.  Treatments include Control (no additive in milk replacer or starter grain) or SCFP 
(diet that contained two proprietary Saccharomyces cerevisiae fermentation products (1 g/hd/d 
SmartCare™ [0.15% inclusion rate in conventional milk replacer] and 3.5 g/hd/d Original XPC™ 
administered orally via gelatin capsule; Diamond V, Cedar Rapids, Iowa).  Data represent the 
mean + SEM for single daily measurements on 20 calves in each group. *P < 0.05 versus SCFP. 
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Figure 3b.  Time course of fecal shedding incidences in Salmonella-infected calves fed SCFP or 
the Control.  Treatments include Control (no additive in milk replacer or starter grain) or SCFP 
(diet that contained two proprietary Saccharomyces cerevisiae fermentation products (1 g/hd/d 
SmartCare™ [0.15% inclusion rate in conventional milk replacer] and 3.5 g/hd/d Original XPC™ 
administered orally via gelatin capsule; Diamond V, Cedar Rapids, Iowa).  Percentages are based 
on the number of calves shedding any detectable amount of Salmonella on a given day, with 
n=20 per group on all days. 
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Figure 4.  Salmonella ileal colonization in Salmonella-infected calves fed SCFP (filled column) or 
the Control (open column).  Treatments include Control (no additive in milk replacer or starter 
grain) or SCFP (diet that contained two proprietary Saccharomyces cerevisiae fermentation 
products (1 g/hd/d SmartCare™ [0.15% inclusion rate in conventional milk replacer] and 3.5 
g/hd/d Original XPC™ administered orally via gelatin capsule; Diamond V, Cedar Rapids, Iowa).  
Data represent the mean + SEM for single measurements on 20 calves in each group. *P <0.05 
versus the Control. 
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Figure 5.  Rumen papillae dimensions in Salmonella-infected calves fed SCFP or the Control.  
Treatments include Control (no additive in milk replacer or starter grain) or SCFP (diet that 
contained two proprietary Saccharomyces cerevisiae fermentation products (1 g/hd/d 
SmartCare™ [0.15% inclusion rate in conventional milk replacer] and 3.5 g/hd/d Original XPC™ 
administered orally via gelatin capsule; Diamond V, Cedar Rapids, Iowa).  Data represent the 
mean + SEM for measurements on 20 calves in each group.  Rumen papillae were measured ten 
times for each animal.  Widths were measured at the mid-shaft of the papillae.  *P <0.05 versus 
the Control. 
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Figure 6.  Representative rumen papillae photomicrographs (40X) of hematoxylin-eosin stained 
sections from Salmonella-infected calves SCFP (top) or the Control (bottom).  Treatments 
include Control (no additive in milk replacer or starter grain) or SCFP (diet that contained two 
proprietary Saccharomyces cerevisiae fermentation products (1 g/hd/d SmartCare™ [0.15% 
inclusion rate in conventional milk replacer] and 3.5 g/hd/d Original XPC™ administered orally 
via gelatin capsule; Diamond V, Cedar Rapids, Iowa). Papillae are longer in calves fed SCFP, 
whereas papillae widths are indistinct.  A 100µm scale bar is present on the bottom right of 
each photo. 
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Figure 7.  Percent body weight gains in Salmonella-infected calves fed SCFP or the Control.  
Treatments include Control (no additive in milk replacer or starter grain) or SCFP (diet that 
contained two proprietary Saccharomyces cerevisiaeࠀfermentation products (1 g/hd/d 
SmartCare™ [0.15% inclusion rate in conventional milk replacer] and 3.5 g/hd/d Original XPC™ 
administered orally via gelatin capsule; Diamond V, Cedar Rapids, Iowa).  Data represent the 
mean + SEM for measurements on 20 calves in each group.  Body weights were measured on d 
0, 14, and 35. *P <0.05 versus the Control. 
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APPENDIX C.  MOLECULAR CLONING OF GPCRS FROM TRYPANOSOMA BRUCEI 
 
 
ABSTRACT 
 
Classical deorphanization of GPCRs often begins with cloning of a putative GPCR.  For this study, 
a PCR strategy was used to clone GPCRs from the genomic DNA of the protozoan parasite 
Trypanosoma brucei.  Approximately 25 pairs of degenerate primers were designed based on a 
multiple sequence alignment of vertebrate and arthropod GPCRs and PCR reactions were 
conducted using all combinations of these 25 pairs.  Secondary PCR reactions were then 
performed on amplicons from the initial reaction by utilizing combinations of primers that 
provided a nested PCR strategy.  Lastly, the amplicons from the nested reaction were utilized as 
the template in a multiplex PCR reaction containing all 25 pairs of primers.  Amplicons of the 
correct size (~1500 BP) were cloned into the TA vector pBAD and sequenced at the ISU DNA 
facility.  BLAST searches of these sequences were conducted in the NCBI database utilizing 
these sequences.  With this approach, a putative GPCR was identified.  These sequences 
contain 7 predicted transmembrane domains and were not present in mammalian databases, 
indicating that our PCR reactions were not contaminated with human DNA.  The sequence for 
this putative receptor are provided. 
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TRYPANOSOMA BRUCEI PUTATIVE GPCR AMINO ACID SEQUENCE 
maffyaifwi sltvlllqcc vsqwltvqas namtnpdlrk vslsllgnlh ydvlfgkpgg 
ygvcnqgqps iatpgcdspl klirsvmrdv skwkesftli tggllrhgtd tiatteiesm 
mkdvvveian ssresylkke gatytvalsf ggtdfipans ftpegkqphf trllnllely 
ellnsqeskk lgncgyffrd lngtklrvis lntllwsnal rpgfgvgdvd pcgqfpflqg 
aieqakqrgr sviilgdtpp vinvadalrk ssvqeaesyw redfteayfr iiatyrfsia 
aqffghtnsf afvdspevgp plyivppisp vtgsnpsylr atldtntgrv vtlkqrylse 
ngkwvegesl edaigaplre mgeslpkdll litesekkwe klaamrvggr fltergacsl 
wcrrviacas lyyskmaier casidlpsqr lglilaivft cfgmlmitfs fgymishyki 
ifhppvvvga gkgrhrlfle hteeefs 
 
